Schedule I
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
1.
Opium poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including:
US: CSA Schedule II Section b Subsection 3 Opium poppy
[Opium the dried sap of the Opium poppy seed head, is a complex mixture of chemicals including Codeine, Morphine, Thebaine and Papaverine.]
(1)
Opium
UK: MDA Part I Class A Section 1(a) Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: Opium
(2)
Codeine (Methylmorphine)
UK: MDA Part II Class B Section 1(a) Codeine
(3)
Morphine (7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol)
UK: MDA Part I Class A Section 1(a) Morphine
(4)
Thebaine (Paramorphine) and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:
Effective 22 Apr 1997, SOR/97-230 replacement for:
Thebaine (Paramorphine) and the salts, derivatives and salts of derivatives of substances set out in subitems (1) to (4), including:
(5)
Acetorphine (Acetyletorphine)
UK: MDA Part I Class A Section 1(a) Acetorphine
UN: Narcotics Part 1 Section 1 Acetorphine and Section 3 Acetorphine
US: CSA Schedule I Section c Subsection 1 Acetorphine
(6)
Acetyldihydrocodeine (4,5-Epoxy-3-methoxy-17-methylmorphinan-6-ol acetate)
UK: MDA Part II Class B Section 1(a) Acetyldihydrocodeine
UN: Narcotics Part 1 Section 2 Acetyldihydrocodeine and Part 2 Section 1 Acetyldihydrocodeine
US: CSA Schedule I Section c Subsection 2 Acetyldihydrocodeine
(7)
Benzylmorphine (7,8-Didehydro-4,5-epoxy-17-methyl-3-(phenylmethoxy)morphinan-6-ol)
UK: MDA Part I Class A Section 1(a) Benzylmorphine
UN: Narcotics Part 1 Section 1 Benzylmorphine
US: CSA Schedule I Section c Subsection 3 Benzylmorphine
(8)
Codoxime (Dihydrocodeinone O-(carboxymethyl)oxime)
UK: MDA Part I Class A Section 1(a) Dihydrocodeinone O-carboxymethyloxime
UN: Narcotics Part 1 Section 1 Codoxime
(9)
Desomorphine (Dihydrodeoxymorphine)
UK: MDA Part I Class A Section 1(a) Desomorphine
UN: Narcotics Part 1 Section 1 Desomorphine and Section 3 Desomorphine
US: CSA Schedule I Section c Subsection 7 Desomorphine
(11)
Dihydrocodeine (4,5-Epoxy-3-methoxy-17-methylmorphinan-6-ol)
UK: MDA Part II Class B Section 1(a) Dihydrocodeine
UN: Narcotics Part 1 Section 2 Dihydrocodeine and Part 2 Section 1 Dihydrocodeine
US: CSA Schedule II Section c Subsection 7 Dihydrocodeine, Schedule III Section e Subsection 1 Item iii Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
(12)
Dihydromorphine (4,5-Epoxy-17-methylmorphinan-3,6-diol)
UK: MDA Part I Class A Section 1(a) Dihydromorphine
UN: Narcotics Part 1 Section 1 Dihydromorphine
US: CSA Schedule I Section c Subsection 8 Dihydromorphine
(13)
Ethylmorphine (7,8-Didehydro-4,5-epoxy-3-ethoxy-17-methylmorphinan-6-ol)
UK: MDA Part II Class B Section 1(a) Ethylmorphine
UN: Narcotics Part 1 Section 2 Ethylmorphine and Part 2 Section 1 Ethylmorphine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
(15)
Hydrocodone (Dihydrocodeinone)
UK: MDA Part I Class A Section 1(a) Hydrocodone
UN: Narcotics Part 1 Section 1 Hydrocodone
US: CSA Schedule II Section b Subsection 1 Item vi Hydrocodone
US: [revoked] CSA Schedule III Section e Subsection 1 Dihydrocodeinone and Dihydrocodeinone
⇒
PubChem: 5284569; ChemSpider: 4447623; Drugs Forum: Hydrocodone; Erowid: Hydrocodone; Wikipedia: Hydrocodone
(16)
Hydromorphinol (Dihydro-14-hydroxymorphine)
UK: MDA Part I Class A Section 1(a) Hydromorphinol
UN: Narcotics Part 1 Section 1 Hydromorphinol
US: CSA Schedule I Section c Subsection 12 Hydromorphinol
(17)
Hydromorphone (Dihydromorphinone)
UK: MDA Part I Class A Section 1(a) Hydromorphone
UN: Narcotics Part 1 Section 1 Hydromorphone
US: CSA Schedule II Section b Subsection 1 Item vii Hydromorphone
⇒
PubChem: 5284570; ChemSpider: 4447624; Drugs Forum: Hydromorphone; Erowid: Hydromorphone; Wikipedia: Hydromorphone
(18)
Methyldesorphine (Δ6-Deoxy-6-methylmorphine)
UK: MDA Part I Class A Section 1(a) Methyldesorphine
UN: Narcotics Part 1 Section 1 Methyldesorphine
US: CSA Schedule I Section c Subsection 13 Methyldesorphine
(19)
Methyldihydromorphine (Dihydro-6-methylmorphine)
UK: MDA Part I Class A Section 1(a) Methyldihydromorphine
UN: Narcotics Part 1 Section 1 Methyldihydromorphine
US: CSA Schedule I Section c Subsection 14 Methyldihydromorphine
(21)
Morphine-N-oxide (Morphine oxide)
UK: MDA Part I Class A Section 1(a) Morphine N-oxide
UN: Narcotics Part 1 Section 1 Morphine-N-oxide
US: CSA Schedule I Section c Subsection 17 Morphine-N-oxide
(23)
Nalorphine (N-Allylnormorphine)
US: CSA Schedule III Section d Subsection d Nalorphine
(24)
Nicocodine (6-Nicotinylcodeine)
UK: MDA Part II Class B Section 1(a) Nicocodine
UN: Narcotics Part 1 Section 2 Nicocodine and Part 2 Section 1 Nicocodine
US: CSA Schedule I Section c Subsection 19 Nicocodeine
(25)
Nicomorphine (Dinicotinylmorphine)
UK: MDA Part I Class A Section 1(a) Nicomorphine
UN: Narcotics Part 1 Section 1 Nicomorphine
US: CSA Schedule I Section c Subsection 20 Nicomorphine
(26)
Norcodeine (N-Desmethylcodeine)
UK: MDA Part II Class B Section 1(a) Norcodeine
UN: Narcotics Part 1 Section 2 Norcodeine and Part 2 Section 1 Norcodeine
(27)
Normorphine (N-Desmethylmorphine)
UK: MDA Part I Class A Section 1(a) Normorphine
UN: Narcotics Part 1 Section 1 Normorphine
US: CSA Schedule I Section c Subsection 21 Normorphine
(29)
Oxymorphone (Dihydrohydroxymorphinone)
UK: MDA Part I Class A Section 1(a) Oxymorphone
UN: Narcotics Part 1 Section 1 Oxymorphone
US: CSA Schedule II Section b Subsection 1 Item xiv Oxymorphone
⇒
PubChem: 5284604; ChemSpider: 4447650; Bluelight: Oxymorphone; Drugs Forum: Oxymorphone; Erowid: Oxymorphone; Wikipedia: Oxymorphone
(30)
Pholcodine (3-[2-(4-Morpholinyl)ethyl]morphine)
UK: MDA Part II Class B Section 1(a) Pholcodine
UN: Narcotics Part 1 Section 2 Pholcodine and Part 2 Section 1 Pholcodine
US: CSA Schedule I Section c Subsection 22 Pholcodine
⇒
PubChem: 5311356; ChemSpider: 4470854; Bluelight: Pholcodine; Drugs Forum: Pholcodine; Wikipedia: Pholcodine
but not including
(32)
Apomorphine (5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Apomorphine (5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol)
(33)
Cyprenorphine (N-(Cyclopropylmethyl)-6,7,8,14-tetrahydro-7α-(1-hydroxy-1-methylethyl)-6,14-endo-ethenonororipavine)
US: CSA Schedule I Section c Subsection 6 Cyprenorphine
Effective 29 Sep 1999, SOR/99-371 added:
Effective 3 Oct 1998, C. Gaz. 1998.I.2535 added:
(34)
Effective 29 Sep 1999, SOR/99-371 renumbered:
(34.1)
Effective 29 Sep 1999, SOR/99-371 renumbered:
Effective 22 Apr 1997, SOR/97-230 added:
(34.2)
Naltrexone (17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one)
[Seeds from inside the dried seed head of the Opium poppy, they contain, at best, only trace amounts of Morphine.]
3.
Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:
UK: MDA Part I Class A Section 1(e) Pethidine [derivatives]
(1)
Allylprodine (3-Allyl-1-methyl-4-phenyl-4-piperidyl propionate)
UK: MDA Part I Class A Section 1(a) Allylprodine
UN: Narcotics Part 1 Section 1 Allylprodine
US: CSA Schedule I Section b Subsection 3 Allylprodine
(2)
Alphameprodine (α-3-Ethyl-1-methyl-4-phenyl-4-piperidyl propionate)
UK: MDA Part I Class A Section 1(a) Alphameprodine
UN: Narcotics Part 1 Section 1 Alphameprodine
US: CSA Schedule I Section b Subsection 5 Alphameprodine
(3)
Alphaprodine (α-1,3-Dimethyl-4-phenyl-4-piperidyl propionate)
UK: MDA Part I Class A Section 1(a) Alphaprodine
UN: Narcotics Part 1 Section 1 Alphaprodine
US: CSA Schedule II Section c Subsection 2 Alphaprodine
(4)
Anileridine (Ethyl 1-[2-(p-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Anileridine
UN: Narcotics Part 1 Section 1 Anileridine
US: CSA Schedule II Section c Subsection 3 Anileridine
(5)
Betameprodine (β-3-Ethyl-1-methyl-4-phenyl-4-piperidyl propionate)
UK: MDA Part I Class A Section 1(a) Betameprodine
UN: Narcotics Part 1 Section 1 Betameprodine
US: CSA Schedule I Section b Subsection 13 Betameprodine
(6)
Betaprodine (β-1,3-Dimethyl-4-phenyl-4-piperidyl propionate)
UK: MDA Part I Class A Section 1(a) Betaprodine
UN: Narcotics Part 1 Section 1 Betaprodine
US: CSA Schedule I Section b Subsection 15 Betaprodine
(7)
Benzethidine (Ethyl 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Benzethidine
UN: Narcotics Part 1 Section 1 Benzethidine
US: CSA Schedule I Section b Subsection 9 Benzethidine
(8)
Diphenoxylate (Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Diphenoxylate
UN: Narcotics Part 1 Section 1 Diphenoxylate and Part 2 Section 6 Diphenoxylate
US: CSA Schedule II Section c Subsection 8 Diphenoxylate and Schedule V Section c Subsection 4 Diphenoxylate
(9)
Difenoxin (1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Difenoxin
(10)
Etoxeridine (Ethyl 1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Etoxeridine
UN: Narcotics Part 1 Section 1 Etoxeridine
US: CSA Schedule I Section b Subsection 28 Etoxeridine
(11)
Furethidine (Ethyl 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Furethidine
UN: Narcotics Part 1 Section 1 Furethidine
US: CSA Schedule I Section b Subsection 29 Furethidine
(12)
Hydroxypethidine (Ethyl 4-(m-hydroxyphenyl)-1-methyl-4-phenylpiperidine-4-carboxylate)
UK: [revoked] MDA Part I Class A Section 1(a) Hydroxypethidine
UN: Narcotics Part 1 Section 1 Hydroxypethidine
US: CSA Schedule I Section b Subsection 30 Hydroxypethidine
(13)
Ketobemidone (1-[4-(m-Hydroxyphenyl)-1-methyl-4-piperidyl]-1-propanone)
UK: MDA Part I Class A Section 1(a) Ketobemidone
UN: Narcotics Part 1 Section 1 Ketobemidone and Section 3 Ketobemidone
US: CSA Schedule I Section b Subsection 31 Ketobemidone
(14)
Methylphenylisonipecotonitrile (4-Cyano-1-methyl-4-phenylpiperidine)
UK: MDA Part I Class A Section 1(a) 4-Cyano-1-methyl-4-phenylpiperidine
UN: Narcotics Part 1 Section 1 Pethidine intermediate A
US: CSA Schedule II Section c Subsection 19 Pethidine-intermediate-A
(15)
Morpheridine (Ethyl 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylate)
[With thanks to Zuo Ning for reporting an error in the chemical name given previously for this substance.]
UK: MDA Part I Class A Section 1(a) Morpheridine
UN: Narcotics Part 1 Section 1 Morpheridine
US: CSA Schedule I Section b Subsection 36 Morpheridine
(16)
Norpethidine (Ethyl 4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) 4-Phenylpiperidine-4-carboxylic acid ethyl ester
UN: Narcotics Part 1 Section 1 Pethidine intermediate B
US: CSA Schedule II Section c Subsection 20 Pethidine-intermediate-B
(18)
Phenoperidine (Ethyl 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Phenoperidine
UN: Narcotics Part 1 Section 1 Phenoperidine
US: CSA Schedule I Section b Subsection 47 Phenoperidine
(19)
Piminodine (Ethyl 1-[3-(phenylamino)propyl]-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Piminodine
UN: Narcotics Part 1 Section 1 Piminodine
US: CSA Schedule II Section c Subsection 23 Piminodine
(20)
Properidine (Isopropyl 1-methyl-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) Properidine
UN: Narcotics Part 1 Section 1 Properidine
US: CSA Schedule I Section b Subsection 50 Properidine
(21)
Trimeperidine (1,2,5-Trimethyl-4-phenyl-4-piperidyl propionate)
UK: MDA Part I Class A Section 1(a) Trimeperidine
UN: Narcotics Part 1 Section 1 Trimeperidine
US: CSA Schedule I Section b Subsection 55 Trimeperidine
(22)
Pethidine intermediate C (1-Methyl-4-phenylpiperidine-4-carboxylate)
UK: MDA Part I Class A Section 1(a) 1-Methyl-4-phenylpiperidine-4-carboxylic acid
UN: Narcotics Part 1 Section 1 Pethidine intermediate C
US: CSA Schedule II Section c Subsection 21 Pethidine-intermediate-C
but not including
(23)
Carbamethidine (Ethyl 1-(2-carbamylethyl)-4-phenylpiperidine-4-carboxylate)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Carbamethidine (Ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate)
The name “Carbamethidine” is unknown outside this legislation, however the chemical name corresponds to a known substance, “Carperidine.”
(24)
Oxpheneridine (Ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Oxpheneridine (Ethyl 1-(2-hydroxy-2,2-phenylethyl)-4-phenylpiperidine-4-carboxylate)
(1)
Proheptazine (Hexahydro-1,3-dimethyl-4-phenyl-1H-azepin-4-ol propionate)
UK: MDA Part I Class A Section 1(a) Proheptazine
UN: Narcotics Part 1 Section 1 Proheptazine
US: CSA Schedule I Section b Subsection 49 Proheptazine
(1)
Dimethylaminodiphenylbutanonitrile (4-Cyano-2-dimethylamino-4,4-diphenylbutane)
UK: MDA Part I Class A Section 1(a) 4-Cyano-2-dimethylamino-4,4-diphenylbutane
UN: Narcotics Part 1 Section 1 Methadone intermediate
US: CSA Schedule II Section c Subsection 16 Methadone-intermediate
(2)
Dipipanone (4,4-Diphenyl-6-piperidino-3-heptanone)
UK: MDA Part I Class A Section 1(a) Dipipanone
UN: Narcotics Part 1 Section 1 Dipipanone
US: CSA Schedule I Section b Subsection 25 Dipipanone
(3)
Isomethadone (6-Dimethylamino-5-methyl-4,4-diphenyl-3-hexanone)
UK: MDA Part I Class A Section 1(a) Isomethadone
UN: Narcotics Part 1 Section 1 Isomethadone
US: CSA Schedule II Section c Subsection 10 Isomethadone
(5)
Normethadone (6-Dimethylamino-4,4-diphenyl-3-hexanone)
UK: MDA Part I Class A Section 1(a) Normethadone
UN: Narcotics Part 1 Section 1 Normethadone
US: CSA Schedule I Section b Subsection 40 Normethadone
(6)
Norpipanone (4,4-Diphenyl-6-piperidino-3-hexanone)
UK: MDA Part I Class A Section 1(a) Norpipanone
UN: Narcotics Part 1 Section 1 Norpipanone
US: CSA Schedule I Section b Subsection 41 Norpipanone
(7)
Phenadoxone (6-Morpholino-4,4-diphenyl-3-heptanone)
UK: MDA Part I Class A Section 1(a) Phenadoxone
UN: Narcotics Part 1 Section 1 Phenadoxone
US: CSA Schedule I Section b Subsection 44 Phenadoxone
(1)
Acetylmethadol (6-Dimethylamino-4,4-diphenyl-3-heptanol acetate)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Acetylmethadol (6-Dimethylamino-4,4-diphenyl-3-heptanyl acetate)
UK: MDA Part I Class A Section 1(a) Methadyl acetate
UN: Narcotics Part 1 Section 1 Acetylmethadol
US: CSA Schedule I Section b Subsection 2 Acetylmethadol
(2)
Alphacetylmethadol (α-6-Dimethylamino-4,4-diphenyl-3-heptanol acetate)
UK: MDA Part I Class A Section 1(a) Alphacetylmethadol
UN: Narcotics Part 1 Section 1 Alphacetylmethadol
US: CSA Schedule I Section b Subsection 4 Alphacetylmethadol
(3)
Alphamethadol (α-6-Dimethylamino-4,4-diphenyl-3-heptanol)
UK: MDA Part I Class A Section 1(a) Alphamethadol
UN: Narcotics Part 1 Section 1 Alphamethadol
US: CSA Schedule I Section b Subsection 6 Alphamethadol
(4)
Betacetylmethadol (β-6-Dimethylamino-4,4-diphenyl-3-heptanol acetate)
UK: MDA Part I Class A Section 1(a) Betacetylmethadol
UN: Narcotics Part 1 Section 1 Betacetylmethadol
US: CSA Schedule I Section b Subsection 10 Betacetylmethadol
(5)
Betamethadol (β-6-Dimethylamino-4,4-diphenyl-3-heptanol)
UK: MDA Part I Class A Section 1(a) Betamethadol
UN: Narcotics Part 1 Section 1 Betamethadol
US: CSA Schedule I Section b Subsection 14 Betamethadol
(6)
Dimepheptanol (6-Dimethylamino-4,4-diphenyl-3-heptanol)
UK: MDA Part I Class A Section 1(a) Dimepheptanol
UN: Narcotics Part 1 Section 1 Dimepheptanol
US: CSA Schedule I Section b Subsection 22 Dimepheptanol
(7)
Noracymethadol (α-6-Methylamino-4,4-diphenyl-3-heptanol acetate)
UK: MDA Part I Class A Section 1(a) Noracymethadol
UN: Narcotics Part 1 Section 1 Noracymethadol
US: CSA Schedule I Section b Subsection 38 Noracymethadol
(1)
Dimenoxadol (Dimethylaminoethyl 1-ethoxy-1,1-diphenylacetate)
UK: MDA Part I Class A Section 1(a) Dimenoxadole
UN: Narcotics Part 1 Section 1 Dimenoxadol
US: CSA Schedule I Section b Subsection 21 Dimenoxadol
(2)
Dioxaphetyl butyrate (Ethyl 2,2-diphenyl-4-morpholinobutyrate)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Dioxaphetylbutyrate (Ethyl 2,2-diphenyl-4-morpholino butyrate)
UK: MDA Part I Class A Section 1(a) Dioxaphetyl butyrate
UN: Narcotics Part 1 Section 1 Dioxaphetyl butyrate
US: CSA Schedule I Section b Subsection 24 Dioxaphetyl butyrate
(3)
Dextropropoxyphene ([S-(R*,S*)]-α-[2-(Dimethylamino)-1-methylethyl]-α-phenylbenzeneethanol, propanoate ester)
UK: MDA Part III Class C Section 1(a) Dextropropoxyphene
UN: Narcotics Part 1 Section 2 Dextropropoxyphene and Part 2 Section 3 Dextropropoxyphene
US: CSA Schedule II Section c Subsection 5 Dextropropoxyphene and Schedule IV Section b Subsection 2 Dextropropoxyphene
(1)
Diethylthiambutene (N,N-Diethyl-1-methyl-3,3-di-2-thienylallylamine)
UK: MDA Part I Class A Section 1(a) Diethylthiambutene
UN: Narcotics Part 1 Section 1 Diethylthiambutene
US: CSA Schedule I Section b Subsection 19 Diethylthiambutene
(2)
Dimethylthiambutene (N,N,1-Trimethyl-3,3-di-2-thienylallylamine)
UK: MDA Part I Class A Section 1(a) Dimethylthiambutene
UN: Narcotics Part 1 Section 1 Dimethylthiambutene
US: CSA Schedule I Section b Subsection 23 Dimethylthiambutene
(3)
Ethylmethylthiambutene (N-Ethyl-N,1-dimethyl-3,3-di-2-thienylallylamine)
UK: MDA Part I Class A Section 1(a) Ethylmethylthiambutene
UN: Narcotics Part 1 Section 1 Ethylmethylthiambutene
US: CSA Schedule I Section b Subsection 26 Ethylmethylthiambutene
(1)
Dextromoramide (d-1-(3-Methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
UK: MDA Part I Class A Section 1(a) Dextromoramide
UN: Narcotics Part 1 Section 1 Dextromoramide
US: CSA Schedule I Section b Subsection 17 Dextromoramide
(2)
Diphenylmorpholinoisovaleric acid (2-Methyl-3-morpholino-1,1-diphenylpropionic acid)
UK: MDA Part I Class A Section 1(a) 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
UN: Narcotics Part 1 Section 1 Moramide intermediate
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
(3)
Levomoramide (l-1-(3-Methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
UK: MDA Part I Class A Section 1(a) Levomoramide
UN: Narcotics Part 1 Section 1 Levomoramide
US: CSA Schedule I Section b Subsection 32 Levomoramide
(4)
Racemoramide (dl-1-(3-Methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
UK: MDA Part I Class A Section 1(a) Racemoramide
UN: Narcotics Part 1 Section 1 Racemoramide
US: CSA Schedule I Section b Subsection 52 Racemoramide
(1)
Buprenorphine (17-(Cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6,14-ethenomorphinan-7-methanol)
UK: MDA Part III Class C Section 1(a) Buprenorphine
UN: Psychotropics Schedule III Buprenorphine
US: CSA Schedule III Section e Subsection 2 Item i Buprenorphine
⇒
PubChem: 40400 644073; ChemSpider: 559124; Bluelight: Buprenorphine; Drugs Forum: Buprenorphine; Erowid: Buprenorphine; Wikipedia: Buprenorphine
(2)
Drotebanol (6β,14-Dihydroxy-3,4-dimethoxy-17-methylmorphinan)
UK: MDA Part I Class A Section 1(a) Drotebanol
UN: Narcotics Part 1 Section 1 Drotebanol
US: CSA Schedule I Section c Subsection 9 Drotebanol
(3)
Levomethorphan (l-3-Methoxy-17-methylmorphinan)
UK: MDA Part I Class A Section 1(a) Levomethorphan
UN: Narcotics Part 1 Section 1 Levomethorphan
US: CSA Schedule II Section c Subsection 12 Levomethorphan
⇒
PubChem: 5362449; ChemSpider: 4642423; Bluelight: Levomethorphan; Drugs Forum: Levomethorphan; Wikipedia: Levomethorphan
(4)
Levorphanol (l-3-Hydroxy-17-methylmorphinan)
UK: MDA Part I Class A Section 1(a) Levorphanol
UN: Narcotics Part 1 Section 1 Levorphanol
US: CSA Schedule II Section c Subsection 13 Levorphanol
⇒
PubChem: 5359272; ChemSpider: 16736212; Bluelight: Levorphanol ; Drugs Forum: Levorphanol ; Erowid: Levorphanol Synthesis; Wikipedia: Levorphanol
(5)
Levophenacylmorphan (l-3-Hydroxy-17-phenacylmorphinan)
UK: MDA Part I Class A Section 1(a) Levophenacylmorphan
UN: Narcotics Part 1 Section 1 Levophenacylmorphan
US: CSA Schedule I Section b Subsection 33 Levophenacylmorphan
(6)
Norlevorphanol (l-3-Hydroxymorphinan)
UK: MDA Part I Class A Section 1(a) Norlevorphanol
UN: Narcotics Part 1 Section 1 Norlevorphanol
US: CSA Schedule I Section b Subsection 39 Norlevorphanol
(7)
Phenomorphan (l-3-Hydroxy-17-(2-phenylethyl)morphinan)
UK: MDA Part I Class A Section 1(a) Phenomorphan
UN: Narcotics Part 1 Section 1 Phenomorphan
US: CSA Schedule I Section b Subsection 46 Phenomorphan
(8)
Racemethorphan (dl-3-Methoxy-17-methylmorphinan)
UK: MDA Part I Class A Section 1(a) Racemethorphan
UN: Narcotics Part 1 Section 1 Racemethorphan
US: CSA Schedule II Section c Subsection 24 Racemethorphan
(9)
Racemorphan (dl-3-Hydroxy-N-methylmorphinan)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Racemorphan (3-Hydroxy-N-methylmorphinan)
UK: MDA Part I Class A Section 1(a) Racemorphan
UN: Narcotics Part 1 Section 1 Racemorphan
US: CSA Schedule II Section c Subsection 25 Racemorphan
but not including
(10)
Dextromethorphan (d-1,2,3,9,10,10a-Hexahydro-6-methoxy-11-methyl-4H-10,4a-iminoethanophenanthrene)
UK: MDA Part I Class A Section 2 Dextromethorphan
⇒
PubChem: 5360696; ChemSpider: 13109865; Bluelight: DXM; Drugs Forum: DXM; Wikipedia: Dextromethorphan
(11)
Dextrorphan (d-1,2,3,9,10,10a-Hexahydro-11-methyl-4H-10,4a-iminoethanophenanthren-6-ol)
UK: MDA Part I Class A Section 2 Dextrorphan
(13)
Levargorphan (l-11-Propargyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol)
Effective 21 Oct 1999, SOR/99-421 replacement for:
Levargorphan (l-11-Propargyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Levangorphan (l-11-Propargyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol)
(14)
Butorphanol (17-(Cyclobutylmethyl)morphinan-3,14-diol)
CA: Currently at CDSA Schedule IV Section 9 Butorphanol
(15)
Nalbuphine (17-(Cyclobutylmethyl)-4,5α-epoxymorphinan-3,6α,14-triol)
CA: Currently at CDSA Schedule IV Section 10 Nalbuphine
⇒
PubChem: 16757775 11957646 12898403 6604372 6603947 5360630 5311304; ChemSpider: 4514550; Wikipedia: Nalbuphine
(1)
Phenazocine (1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocin-8-ol)
UK: MDA Part I Class A Section 1(a) Phenazocine
UN: Narcotics Part 1 Section 1 Phenazocine
US: CSA Schedule II Section c Subsection 22 Phenazocine
(2)
Metazocine (1,2,3,4,5,6-Hexahydro-3,6,11-trimethyl-2,6-methano-3-benzazocin-8-ol)
UK: MDA Part I Class A Section 1(a) Metazocine and Part II Class B Section 1(a) Metazocine
UN: Narcotics Part 1 Section 1 Metazocine and Psychotropics Schedule III Metazocine
US: CSA Schedule II Section c Subsection 14 Metazocine
(3)
Pentazocine (1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol)
US: CSA Schedule IV Section g Subsection 1 Pentazocine
⇒
PubChem: 4736; ChemSpider: 390041; Bluelight: Pentazocine; Drugs Forum: Pentazocine; Wikipedia: Pentazocinebut not including
(4)
Cyclazocine (1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(cyclopropylmethyl)-2,6-methano-3-benzazocin-8-ol)
⇒
PubChem: 24039373 24013863 23986637 23955932 21779964 11957515 10038849 10016044 3037926; ChemSpider: 2301549; Wikipedia: Cyclazocine
(1)
Diampromide (N-[2-(Methylphenethylamino)propyl]propionanilide)
UK: MDA Part I Class A Section 1(a) Diampromide
UN: Narcotics Part 1 Section 1 Diampromide
US: CSA Schedule I Section b Subsection 18 Diampromide
(2)
Phenampromide (N-[2-(1-Methyl-2-piperidino)ethyl]propionanilide)
UK: MDA Part I Class A Section 1(a) Phenampromide
UN: Narcotics Part 1 Section 1 Phenampromide
US: CSA Schedule I Section b Subsection 45 Phenampromide
(1)
Clonitazene (2-(p-Chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole)
UK: MDA Part I Class A Section 1(a) Clonitazene
UN: Narcotics Part 1 Section 1 Clonitazene
US: CSA Schedule I Section b Subsection 16 Clonitazene
(2)
Etonitazene (2-(p-Ethoxybenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole)
UK: MDA Part I Class A Section 1(a) Etonitazene
UN: Narcotics Part 1 Section 1 Etonitazene
US: CSA Schedule I Section b Subsection 27 Etonitazene
(3)
Bezitramide (1-(3-Cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine)
UK: MDA Part I Class A Section 1(a) Bezitramide
UN: Narcotics Part 1 Section 1 Bezitramide
US: CSA Schedule II Section c Subsection 4 Bezitramide
14.
Phencyclidine (1-(1-Phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
Effective 31 Aug 2005, SOR/2005-271 replacement for:
UK: MDA Part I Class A Section 1(a) Phencyclidine
UN: Psychotropics Schedule II Phencyclidine (PCP)
US: CSA Schedule II Section e Subsection 4 Phencyclidine
⇒
PubChem: 6468; ChemSpider: 6224; Bluelight: PCP; Drugs Forum: Phencyclidine; Erowid: PCP; Wikipedia: Phencyclidine
Effective 31 Aug 2005, SOR/2005-271 added:
(1)
Ketamine (2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone)
15.
Piritramide (1-(3-Cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide), its salts, derivatives and salts of derivatives
UK: MDA Part I Class A Section 1(a) Piritramide
UN: Narcotics Part 1 Section 1 Piritramide
US: CSA Schedule I Section b Subsection 48 Piritramide
16.
Fentanyls, their salts, derivatives and analogues and salts of derivatives and analogues, including:
UK: MDA Part I Class A Section 1(d) Fentanyl [derivatives]
(1)
Acetyl-α-methylfentanyl (N-[1-(α-Methylphenethyl)-4-piperidyl]acetanilide)
UK: MDA Part I Class A Section 1(d) Acetyl-α-methylfentanyl
UN: Narcotics Part 1 Section 1 Acetyl-alpha-methylfentanyl and Section 3 Acetyl-alpha-methylfentanyl
US: CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
(2)
Alfentanil (N-[1-[2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide)
UK: MDA Part I Class A Section 1(a) Alfentanil
UN: Narcotics Part 1 Section 1 Alfentanil
US: CSA Schedule II Section c Subsection 1 Alfentanil
(3)
Carfentanil (Methyl 4-[(1-oxopropyl)phenylamino]-1-(2-phenethyl)-4-piperidinecarboxylate)
UK: MDA Part I Class A Section 1(a) Carfentanil
US: CSA Schedule II Section c Subsection 6 Carfentanil
(4)
p-Fluorofentanyl (4ʹ-Fluoro-N-(1-phenethyl-4-piperidyl)propionanilide)
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
UN: Narcotics Part 1 Section 1 Para-Fluorofentanyl and Section 3 Para-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
(6)
β-Hydroxyfentanyl (N-[1-(β-Hydroxyphenethyl)-4-piperidyl]propionanilide)
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl and Section 3 Beta-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
(7)
β-Hydroxy-3-methylfentanyl (N-[1-(β-Hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide)
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
(8)
α-Methylfentanyl (N-[1-(α-Methylphenethyl)-4-piperidyl]propionanilide)
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylfentanyl and Section 3 Alpha-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
(9)
α-Methylthiofentanyl (N-[1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl and Section 3 Alpha-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
(10)
3-Methylfentanyl (N-(3-Methyl-1-phenethyl-4-piperidyl)propionanilide)
UK: MDA Part I Class A Section 1(d) 3-Methylfentanyl
UN: Narcotics Part 1 Section 1 3-Methylfentanyl and Section 3 3-Methylfentanyl
US: CSA Schedule I Section b Subsection 34 3-Methylfentanyl
(11)
3-Methylthiofentanyl (N-(3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl)propionanilide)
UK: MDA Part I Class A Section 1(d) 3-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 3-Methylthiofentanyl and Section 3 3-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 35 3-Methylthiofentanyl
Effective 29 Sep 1999, SOR/99-371 added:
Effective 3 Oct 1998, C. Gaz. 1998.I.2535 added:
(11.1)
Remifentanil (Dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)
UK: MDA Part I Class A Section 1(a) Remifentanil
UN: Narcotics Part 1 Section 1 Remifentanil
US: CSA Schedule II Section c Subsection 26 Remifentanil
(12)
Sufentanil (N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)
UK: MDA Part I Class A Section 1(a) Sufentanil
UN: Narcotics Part 1 Section 1 Sufentanil
US: CSA Schedule II Section c Subsection 27 Sufentanil
⇒
PubChem: 41693; ChemSpider: 38043; Bluelight: Sufentanil; Erowid: Sufentanil total synthesis; Wikipedia: Sufentanil
(13)
Thiofentanyl (N-[1-[2-(2-Thienyl)ethyl]-4-piperidyl]propionanilide)
UK: MDA Part I Class A Section 1(d) Thiofentanyl
UN: Narcotics Part 1 Section 1 Thiofentanyl and Section 3 Thiofentanyl
US: CSA Schedule I Section b Subsection 53 Thiofentanyl
Effective 20 Sep 2012, SOR/2012-176 added:
17.1
Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
EU: Substances Substances 3,4-Methylenedioxypyrovalerone
UK: MDA Part II Class B Section 1(aa) MDPV
US: CSA Schedule I Section d Subsection 37 3,4-Methylenedioxypyrovalerone
18.
Methamphetamine (N,α-Dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
Effective 15 Nov 2005, SOR/2005-337 replacement for:
Effective 10 Aug 2005, SOR/2005-235 added:
Methamphetamine (N,α-Dimethylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
On 21 Jun 2007, C. Gaz. 2007.I.2000 proposed to add:
19.
Tramadol ((1R,2R)-rel-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol) and its salts
UK: MDA Part III Class C Section 1(a) Tramadol
US: CSA Schedule IV Section b Subsection 3 2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
19.
Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
CA: Previously at CDSA Schedule III Section 1 Amphetamines
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(1)
Amphetamine (α-Methylbenzeneethanamine)
UK: MDA Part II Class B Section 1(a) Amphetamine
UN: Psychotropics Schedule II Amfetamine (Amphetamine)
US: CSA Schedule II Section d Subsection 1 Amphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 1 Amphetamine
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: Amphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(2)
N-Ethylamphetamine (N-Ethyl-α-methylbenzeneethanamine)
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(3)
4-Methyl-2,5-dimethoxyamphetamine (2,5-Dimethoxy-4,α-dimethylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(4)
3,4-Methylenedioxyamphetamine (MDA) (α-Methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(5)
2,5-Dimethoxyamphetamine (2,5-Dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(6)
4-Methoxyamphetamine (4-Methoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(7)
2,4,5-Trimethoxyamphetamine (2,4,5-Trimethoxy-α-methylbenzeneethanamine)
EU: Substances Substances TMA-2
UK: MDA Part I Class A Section 1(c) 2,4,5-Trimethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 8 2,4,5-Trimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(8)
N-Methyl-3,4-methylenedioxyamphetamine (N,α-Dimethyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(9)
4-Ethoxy-2,5-dimethoxyamphetamine (4-Ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethoxy-2,5-dimethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 10 4-Ethoxy-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(10)
5-Methoxy-3,4-methylenedioxyamphetamine (7-Methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
US: CSA Schedule I Section d Subsection 8 5-Methoxy-3,4-methylenedioxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 11 5-Methoxy-3,4-methylenedioxyamphetamine
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(11)
N,N-Dimethyl-3,4-methylenedioxyamphetamine (N,N,α-Trimethyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(ba) Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
CA: Previously at CDSA Schedule III Section 1 Subsection 12 N,N-Dimethyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(12)
N-Ethyl-3,4-methylenedioxyamphetamine (N-Ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(13)
4-Ethyl-2,5-dimethoxyamphetamine (4-Ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(14)
4-Bromo-2,5-dimethoxyamphetamine (4-Bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(15)
4-Chloro-2,5-dimethoxyamphetamine (4-Chloro-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 16 4-Chloro-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(16)
4-Ethoxyamphetamine (4-Ethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 17 4-Ethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(17)
Benzphetamine (N-Benzyl-N,α-dimethylbenzeneethanamine)
UK: MDA Part III Class C Section 1(a) Benzphetamine
UN: Psychotropics Schedule IV Benzfetamine (Benzphetamine)
US: CSA Schedule III Section b Subsection 2 Benzphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 18 Benzphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(18)
N-Propyl-3,4-methylenedioxyamphetamine (α-Methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Propyl-3,4-methylenedioxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 19 N-Propyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(19)
N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
CA: Previously at CDSA Schedule III Section 1 Subsection 20 N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(20)
N-Hydroxy-3,4-methylenedioxyamphetamine (N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
(21)
3,4,5-Trimethoxyamphetamine (3,4,5-Trimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
US: CSA Schedule I Section d Subsection 14 3,4,5-Trimethoxyamphetamine
CA: Previously at CDSA Schedule III Section 1 Subsection 22 3,4,5-Trimethoxyamphetamine
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
20.
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Flunitrazepam
UN: Psychotropics Schedule III Flunitrazepam
US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
CA: Previously at CDSA Schedule III Section 25 Flunitrazepam
See also CDSA Schedule IV Section 18 Subsection 33 Flunitrazepam
⇒
PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
Effective 6 Nov 2012, S.C. 2012, c. 1 added:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to add:
21.
4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
CA: Previously at CDSA Schedule III Section 26 4-Hydroxybutanoic acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Effective 16 Jul 2015, SOR/2015-190 added:
Effective 26 Feb 2011, C. Gaz. 2011.I.656 added:
22.
Tapentadol (3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers
UK: MDA Part I Class A Section 1(a) Tapentadol
US: CSA Schedule II Section c Subsection 28 Tapentadol
⇒
PubChem: 9838022; ChemSpider: 8013742; Bluelight: Tapentadol; Drugs Forum: Tapentadol; Erowid: Tapentadol; Wikipedia: TapentadolSchedule II
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
1.
Cannabis, its preparations and derivatives, including:
Effective 16 Jul 2015, SOR/2015-192 replacement for:
Cannabis, its preparations, derivatives and similar synthetic preparations, including:
[Cannabis and Cannabis resin contain a complex mixture of chemicals including Cannabidiol, Cannabinol and Tetrahydrocannabinol.]
(1)
Cannabis resin
UK: MDA Part II Class B Section 1(a) Cannabis resin
UN: Narcotics Part 1 Section 1 Cannabis resin and Section 3 Cannabis resin
See also CDSA Schedule VII Section 1 Cannabis resin and Schedule VIII Section 1 Cannabis resin
(3)
Cannabidiol (2-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol)
The chemical name as given in the legislation is silent about the configuration of the two stereogenic centres. The diagram at left depicts the (1R,6R) stereoisomer.
⇒
PubChem: 644019 26346; ChemSpider: 559095; Drugs Forum: Cannabidiol; Erowid: Cannabis; Wikipedia: Cannabidiol
(4)
Cannabinol (3-n-Amyl-6,6,9-trimethyl-6-dibenzopyran-1-ol)
UK: MDA Part II Class B Section 1(a) Cannabinol and Cannabinol
Effective 16 Jul 2015, SOR/2015-192 revoked:
(5)
Nabilone ((±)-trans-3-(1,1-Dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)
CA: Currently at CDSA Schedule II Section 2 Subsection 1 Nabilone
Effective 16 Jul 2015, SOR/2015-192 revoked:
(6)
Pyrahexyl (3-n-Hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6-dibenzopyran-1-ol) [sic]
The chemical name the CDSA provides is wrong. One accepted chemical name is 3-n-Hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol.
CA: Currently at CDSA Schedule II Section 2 Subsection 1 Parahexyl
(7)
Tetrahydrocannabinol (Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol)
The CDSA is silent about which regio- and stereoisomers (ca. 12) of Tetrahydrocannabinol are encompassed by this entry. The (6aR) Δ9 isomer is depicted at left.
UK: MDA Part II Class B Section 1(a) Tetrahydrocannabinol
US: CSA Schedule I Section d Subsection 31 Δ1 cis or trans Tetrahydrocannabinol
⇒
PubChem: 16078; ChemSpider: 4479482; Bluelight: Tetrahydrocannabinol; Erowid: Cannabis; Wikipedia: TetrahydrocannabinolEffective 30 Jan 2003, SOR/2003-32 added:
Effective 16 Jul 2015, SOR/2015-192 revoked:
(7.1)
DMHP (3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol)
CA: Currently at CDSA Schedule II Section 2 Subsection 1 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
but not including
(8)
Non-viable Cannabis seed, with the exception of its derivatives
Effective 12 Mar 1998, SOR/98-157 replacement for:
Non-viable Cannabis seed
There is much confusion about the legality of Cannabis seed. Some believe that because the seeds contain no Tetrahydrocannabinol (or any other controlled substance) they are beyond the reach of the CDSA, but that is not the case.
While it is true that Cannabis seed is not explicitly listed in the CDSA as a controlled material, the Cannabis plant is controlled by the CDSA, and Cannabis seed is considered part of the Cannabis plant.
Furthermore, since the CDSA explicitly excludes “non-viable Cannabis seed” (i.e. a seed that cannot germinate and grow into a Cannabis plant) the courts have made the reasonable inference that the CDSA includes viable Cannabis seed.
The trial judge in R. v. Hunter, 1997 CanLII 1340 (BC S.C.) and the appeal judge in R. v. Hunter, 2000 BCCA 363 (CanLII) each make it plain that to possess (viable) Cannabis seed is an offence under the CDSA.
The fact that police have been less than rigorous in laying charges for this offence, or that the punishment meted out is often trifling, does not nullify the law.
![3D rendering of ((3S)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone](data:image/png;base64,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 "Click for a 3D rendering of ((3S)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone")
Effective 16 Jul 2015, SOR/2015-192 added:
2.
Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers—with the exception of ((3S)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts—including those that fall within the following core chemical structure classes:
Effective 16 Jul 2015, SOR/2015-192 added:
(1)
Any substance that has a 2-(Cyclohexyl)phenol structure with substitution at the 1-position of the benzene ring by a hydroxy, ether or ester group and further substituted at the 5-position of the benzene ring, whether or not further substituted on the benzene ring to any extent, and substituted at the 3′-position of the cyclohexyl ring by an alkyl, carbonyl, hydroxyl, ether or ester, and whether or not further substituted on the cyclohexyl ring to any extent, including
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
Nabilone ((±)-trans-3-(1,1-Dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)
Effective 16 Jul 2015, SOR/2015-192 added:
(ii)
Parahexyl (3-Hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol)
![3D rendering of 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol")
Effective 16 Jul 2015, SOR/2015-192 added:
(iii)
3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)
UN: Psychotropics Schedule I DMHP
Effective 16 Jul 2015, SOR/2015-192 added:
(iv)
Effective 16 Jul 2015, SOR/2015-192 added:
(v)
5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol (CP 47,497)
UK: MDA Part II Class B Section 1(c) CP 47,497
US: CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
⇒
PubChem: 15942731; ChemSpider: 10205286; Drugs Forum: CP 47,497; Erowid: Spice Product; Wikipedia: CP 47,497
Effective 16 Jul 2015, SOR/2015-192 added:
(2)
Any substance that has a 3-(1-Naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
UK: MDA Part II Class B Section 1(c) 3-(1-Naphthoyl)indole
US: CSA Schedule I Section ii Item ii 3-(1-Naphthoyl)indole
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
1-Pentyl-3-(1-naphthoyl)indole (JWH-018)
UK: MDA Part II Class B Section 1(c) JWH-018
US: CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
Effective 16 Jul 2015, SOR/2015-192 added:
(ii)
1-Butyl-3-(1-naphthoyl)indole (JWH-073)
UK: MDA Part II Class B Section 1(c) JWH-073
US: CSA Schedule I Section g Subsection 4 1-Butyl-3-(1-naphthoyl)indole
⇒
PubChem: 10471670; ChemSpider: 8647081; Bluelight: JWH-073; Erowid: Spice Product; Wikipedia: JWH-073
Effective 16 Jul 2015, SOR/2015-192 added:
(iii)
Effective 16 Jul 2015, SOR/2015-192 added:
On 5 Feb 2016, 81 FR 6190 proposed to add:
(iv)
1-Hexyl-3-(1-naphthoyl)indole (JWH-019)
US: CSA Schedule I Section g Subsection 5 1-Hexyl-3-(1-naphthoyl)indole
Effective 16 Jul 2015, SOR/2015-192 added:
On 5 Feb 2016, 81 FR 6190 proposed to add:
(v)
1-(4-Pentenyl)-3-(1-naphthoyl)indole (JWH-022)
Effective 16 Jul 2015, SOR/2015-192 added:
(vii)
1-Butyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081)
UK: MDA Part II Class B Section 1(c) JWH-081
US: CSA Schedule I Section g Subsection 8 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole
Effective 16 Jul 2015, SOR/2015-192 added:
(viii)
1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole (JWH-200)
UK: MDA Part II Class B Section 1(c) JWH-200
US: CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
⇒
PubChem: 10045570; ChemSpider: 8221134; Drugs Forum: JWH-200; Erowid: Spice Product; Wikipedia: JWH-200
Effective 16 Jul 2015, SOR/2015-192 added:
On 5 Feb 2016, 81 FR 6190 proposed to add:
(ix)
Effective 16 Jul 2015, SOR/2015-192 added:
On 5 Feb 2016, 81 FR 6190 proposed to add (and to renumber subsequent entries):
(x)
1-Pentyl-3-(2-methoxy-1-naphthoyl)indole (JWH-267)
![3D rendering of 1-[(N-Methylpiperidin-2-yl)methyl]-3(1-naphthoyl)indole](data:image/png;base64,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 "Click for a 3D rendering of 1-[(N-Methylpiperidin-2-yl)methyl]-3(1-naphthoyl)indole")
Effective 16 Jul 2015, SOR/2015-192 added:
(xi)
Effective 16 Jul 2015, SOR/2015-192 added:
(xii)
Effective 16 Jul 2015, SOR/2015-192 added:
(xiv)
1-(5-Fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole (EAM-2201)
![3D rendering of ((3R)-2,3-Dihydro-5-methyl-3(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPAAAADlCAIAAADiLO3tAAAACXBIWXMAAC4jAAAuIwF4pT92AAAAHXRFWHRTb2Z0d2FyZQBHUEwgR2hvc3RzY3JpcHQgOC42MG0jaeMAAA5wSURBVHic7d2/juNUGwbwN58W2HLOVFsgITl7B84FgBT3NB6JeiXnEuyG3nMFYCNuIFNQUjgSNHTJbg3ILlYIiQK7BYF0vuIsHm8SO459/thnnl+BdjJMfOI8Pj5xkvddcM4JwBb/Mz0AAJkQaLAKAg1WQaDBKgg0WAWBBqsg0GAVBBqsgkCDVRBosAoCDVZBoMEqCDRYBYEGqyDQYBUEGga6v7+/vb31PO9wOJgeyyMEGq622+2Wy2UURUEQVFW1Wq2iKKqqyvS4iIiIA/SW5/l6vSYi3/fzPBc3JknCGGOMxXFsdniccwQaeinLMgxDInJdN8uyq36rEwINl8VxLObgJEmOflXP07xl/tYMgYYuWZY5jkNEYRiWZXn0K9d1GWNn/4QxdvonGiDQcF7HdJvnue/7RLRer9tm4jAMGWOO45xO6koh0HCsXhA7jnO0IO741dn7CYJA5H6/36sc8iME2pyy5EHAGeNEnDEeBFz7CfpUxyWLYVczsiwTM30QBBpWIAi0IWXJGeNhyMUpO895GHLGDGZarInblsttK+mekiQRC2vVl/YQaEOCgIfh8Y1hyINA/1g61sT1SrpjudzTVcuVwRBoQxjjp/nIc35y0UCpPstluZeW64NH0aU9BNqQtvdo9b536/v+2WVAx4VnKepLe9LvGYE2ZBoz9Hq9Dt9f+YxfLveUZZmKT17gw0mG+D6l6fGNaUq+b2I0RESHw8HzPM/zXNfN81xM0nI3cX9/f3d3J/c+jzxTeu/QKo5puSQiCgJyHCoKSlNKU8pzUyMSn5irr7KpUFWV6g/lIdCGMEZ5TlFEqxVVFTFGvk95TrInxf7EGmDuEGhzGKMkoSQxPQ6rYA1tzJ9//rnb7eofX79+/euvvxocjx0QaGPevHnjeV79YxiG3377rcHx2AGBBqsg0GAVBBqsgkCDVRBosAoCDVZBoMEqCDRYBYEGqyDQYBUEGqyCQINVEGiwCgIN70RRtNlsplLmeSgEGt5xXVdUMr+/vzc9luEQaHjH9/39fh8EQRRFy+Wy+eUDiZsQ1e7UmVCg0zT1PC89/S60pRhjNzc3URQtFovNZvPhhx9K/5Z1tzRND4fDbrersytqdOR57rqu53l3d3dFUUjcouu6ospMURRpmip5vNILIwxQf9O4/q/ZKvB6JElyc3Mj6ig7jnNzcxOeFgdTo1lAsa1mrroCHXWl3e12K/FuBcOBzvP8qOLqfr+v97WpKvCqnS2LqPRprp0tcbvdbttKlMstodTc0Ph7O8tYoEXptLanUMMjN6K7VPjp4S1X9zHTVqK8eQwMPnNqm6fMBLourtrMa1mWR9ODnklLj+4DuKmjrO1gPdtEdGS3mcirRqW5n5DuQHeUvxaFA4+mB9WTlh5nD+CLfyKlV9qARj4ds+m1Z07VRR9P6Qv0xWh2HMqaq8BLNGbkI+e2kX/etrDueapRcZ7pQ0eg+59teeeMMmCeM0jWuWVYrzRZE3zbwrr5YuB0wBdbCqmjPNDDUth2zUhPFfiRrjqAe+rfK0361NjR+yfLsqNXQfUDN/XsKAz0+HVCn+lhapf2lJ5GunulNc8J0nfLxWdzIudPJYGW+Equ43W3qVVam8HXAa7SNl/quSJ0NrV6HnhPkgPdXBJI3LMdr7un0DldypXaqzTnS81TY3NdkSSJ5gd+keRAi0tvivZs9+tuuZ8IuJb+lqn8v/ny7HGuWn0SNvLAOyw45xKfV9HQII5j8ePhcBCrAomiKBKfa4nj2G80cPjss89evHjx6tUruZtr03xonucpLXzfIYqiw+FQ1ypXscM7HD3dU6Cw4Plut/M8T+4BQ0RxHAdBILp1rNfrOI7FU/js2bNPPvlET6p2u10URdIf2nir1crUoTURE/r4aH/iNCempc1mY3o4MCEzbkmxXq+f8lQEZ81yhgZog0CDVRBosAoCDVZBoMEqCDRYBYEGqyDQYBUEGqyCQINVEGiwCgINVkGgwSoINFgFgQarzDvQRVGoqMsN8zXXQFdVFUXRarWadf+E2SmKYrPZRFFkeiCtFAZaVBdQcc8PDw+r1SpN0yAI6u+H6qTuoU2WmEFEq4rmd5OnRmGgXdcty1LufR4OB9EqQZRZaX7f+O3btz///LPczbVpPjTRNurNmzd6Nt2tLmAiV5qmy+UyTdO6YYX0TUgjtyqCqI+hohRVnxJKijbdQVTG+Oijj8hQ3SBRr1ZdkZ2O8lSqNz2M/FJgKip0dRS5a1Zz01kc7Kj+lanKbuqqV9ZVT0/nCHXtV8ZTVaxRVqXrjvYfbdXcVBfZrjN0dK5QUXS0p7p65VUld9t0FJYeVttXJ4XVR0cW3O7YdxdryzYzJ7fu/8WjxWDLASkTZ9sD1NxZYjDl9aEHdIuRNUPIrYp51XrGYMuBwSeojuNBf2eJwTS1pOjfm+PiDHHtYrFe3Q5++TK47rLBhfVVRUEvngynuVw+S1+PlYtLzP1+37bvRoZyzOly5LLY4MK6zwmqjv4cl8tn6e6C1THbhWF4uu8kLhuaz9Dvv/9+8f/v3wWiz6ZNtRzoODeWZdnWmHD6fT/amOlT2Gc92nYxYfymHcf5/PPPxY9E/OiJri/NS5+cTLUcaGt9UpZllmWnJ0PjBeTHMNkauWPfqX4V8s0334h/EHHH4c3jpQ60osnJVGIuniWm1uJjGMO9vk9Xt5p3KxHPMu44vN6U7DdPzzB4Tj+7e6fchOlahgMt1Kvbjz/+WPNuFfH1/ceFh4ZACx2t/lRrngDnu1w+axKBFrbbLRF9+eWXOjcq4pvnnDEu3gbRFmghyzL9HVJ44ywx3+XyWZJ7rIy0WCw0d1RYLEjsgPt7enig/f7xlqegKArLPgo71w/4SyfaaE34k+tKiCt6pkch04xbUkgXx+R5pgcB42CGfrReUxCYHgSM89QDfbRcTpIntIC20lMPtPD69WsPqw0rINBERGVZohyCHRBosAoCDVZBoMEqCDRYBYEGqyDQYBUEGqyCQINVEGiwyrQCHcfxy5cvTY8CZmxaHx8V36EAGGwaM3RV0WZDt7e0WNDtLW02VFWmxwSzNIFAVxUtl8QY7ffEOe33xBgtl8g0DDCB7xRuNsQYNWrxExFFEVUVJYmeIex2O8/zzO8KGG0CM/TDw5kvigQBPTyYGA3M2wQCXVXkOMc3Oo62JUdRFGmain+nafqAA2nOJhBoxqgojm8sClL/beS6N9zhcNhut4fDYbPZVFi7z9kEAu379N8E+ShNSXHvsDRN695woojRw8OD67qiOOrhcLi9vVU6AFDCcKEbznlZcsZ4GHJRPSjPeRhyxkS1ue+++056VaE+5fXX63VdoSvP87lXfHs6JhBoznlZ8iDgjHEizhgPgrp24ldffUXyCjc2S9t3NEBJkoSI6v9hvV77vj9+66DBNALdSVZp3bbecKfyPK+r7Ytw14UMwzDU3AoIrjKDQPPRLZg6esNd5DhOEATi3yLcWH5M2TwCLQxoqDXgT47U62zRwKFu7LDdbl3XHXCHoNScAi30nG6l99UTK5Z6i82ZO8/z+Za8t8z8Ai10L4hVdLRo3pvYupjyy7J0HEdz4zZoM9dA85ZLFhr66h2tPY5mbjBrxoEW6ovKX3zxxaeffkrq++qJ6f/swhqMm8A7heOIpm9Jknz//fdv377NskwsstVtUSzKRZ3w+/t7Ivr777/xCZCJmMDHR2erKIrlcpkkiXjPPD76BCyYMPsZ2iCx2AhQJH1KEOjhRP8o06OA9yDQYBUEGqyCQINVEGiwCgINVkGgwSoINFgFgQarINBgFQQarIJAg1UQaLAKAg1WQaDBKtNqSTFTr169evHihelRABG+sQKWwZJjuMWCVqvjMtaLhaHRABEh0ONFkekRQAMCPUqSUJqeKW8NpiDQo7guxTFFER0OpocCRIQXhWMsFiR2nudRVVGWEWOPN4IRmKEl2G6pKLCYngRchx7in3/++eCDD+ofGaMkobu7x25ef/311/Pnz80M7mnDDH21KIp++umnoxt9n8LwcZL++uuvRZUw0M1wbb1Zqavm/fLLL5zzo51Xltx13934ww8/EJHjOHVrC9ADge5lQCeAPM/7NCgCuRDoC5pVqAd0Ami2kENzFg0Q6C79G2d1S5JkcNciuAoCfd6YxlltZB0e0AGBPja+cVaHegEjq5URHEGgH41cLveX57k4ZlR3z3iCEOh39K8HNPQ3eoIQaM45z7LMVLCSJBGF0zVv11Z4p/CRaG+leaNBELiuWx19TQCGQqDBKgg0WAWBBqsg0GAVBBqsgkCDVRBosAoCDVZBoMEqCDRYBYEGqyDQYBUEGqyCQINVEGiwCgINVkGgwSoINFgFgQarINBgFQQarIJAm/fvv/+aHoI9EGgioj/++IOI7u7uiqLQud2qqjabzY8//vjbb7/p3K7NTBcGmQr9dYxQu1EFBPo9otaM6pDVnQBQBEw6BPqY0pKNKNOoGgJ9XrOorpRJtCzLMAwJhXQVQ6C7NCvvj7kfsZJhjGG5rBoCfYGYWcXCeliPFSyXdUKge8nz3Pd9sbDu3wULy2X9EOgrZFnmuu571zrLkgcBZ4wTccZ4EPD/pmEsl43AGytXEB0H4zh+93NV0XJJjNF+T5zTfk+M0XJJVUVEcRzXryxBmwXn3PQYZmuzIcaozrcQRVRVlCSGxvTUIdAj3N7Sfv/YsV4oClqtqCwNjempQ6BHWCzo7N5rux3Uwxp6BMbo9MNMRUHaG7VADYEewfcpTY9vTFPyfROjASKiZ6YHMGdxTMslEVEQkONQUVCaUppSnpse2dOFGXoExijPqapotaLFglYrqirKcyw5DMKLQrAKZmiwCgINVkGgwSoINFgFgQarINBgFQQarIJAg1UQaLAKAg1WQaDBKgg0WAWBBqsg0GAVBBqsgkCDVf4P0bI4YEQ1l5IAAAAASUVORK5CYII= "Click for a 3D rendering of ((3R)-2,3-Dihydro-5-methyl-3(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone")
Effective 16 Jul 2015, SOR/2015-192 added:
(xv)
((3R)-2,3-Dihydro-5-methyl-3(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55212-2)
⇒
PubChem: 5311501; ChemSpider: 4470978; Bluelight: WIN 55,212-2; Drugs Forum: WIN 55,212-2; Wikipedia: WIN_55,212-2
Effective 16 Jul 2015, SOR/2015-192 added:
(3)
Any substance that has a 3-(1-Naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
UK: MDA Part II Class B Section 1(c) 3-(1-Naphthoyl)pyrrole
US: CSA Schedule I Section iii Item iii 3-(1-Naphthoyl)pyrrole
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
Effective 16 Jul 2015, SOR/2015-192 added:
(4)
Any substance that has a 3-Phenylacetylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
UK: MDA Part II Class B Section 1(c) 3-Phenylacetylindole
US: CSA Schedule I Section v Item v 3-Phenylacetylindole
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
Effective 16 Jul 2015, SOR/2015-192 added:
(ii)
Effective 16 Jul 2015, SOR/2015-192 added:
(5)
Any substance that has a 3-Benzoylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
UK: MDA Part II Class B Section 1(c) 3-Benzoylindole
US: CSA Schedule I Section v Item v 3-Benzoylindole
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
Effective 16 Jul 2015, SOR/2015-192 added:
(6)
Any substance that has a 3-Methanone(cyclopropyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the cyclopropyl ring to any extent, including
The Open Parser for Systematic IUPAC nomenclature (OPSIN), a superlative work of software design and engineering in my view, quite properly says “3-methanone(cyclopropyl)indole” circumvents the rules and offends the language of chemistry: “3-methanone(cyclopropyl)indole has no tokens unknown to OPSIN but does not conform to its grammar. From left to right it is unparsable due to the following being uninterpretable:(cyclopropyl)indole”
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
(1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)-methanone (UR-144)
UK: MDA Part II Class B Section 1(c) UR-144
US: CSA Schedule I Section h Subsection 1 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 16 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
-methanone](data:image/png;base64,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 "Click for a 3D rendering of [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone")
Effective 16 Jul 2015, SOR/2015-192 added:
(ii)
[1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone (5F-UR-144)
UK: MDA Part II Class B Section 1(c) XLR11
US: CSA Schedule I Section h Subsection 2 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 17 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
Effective 16 Jul 2015, SOR/2015-192 added:
(iii)
Effective 16 Jul 2015, SOR/2015-192 added:
(7)
Any substance that has a Quinolin-8-yl 1H-indole-3-carboxylate structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the quinolin-8-yl ring to any extent, including
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22)
The Open Parser for Systematic IUPAC nomenclature (OPSIN), a superlative work of software design and engineering in my view, quite properly says “1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid” circumvents the rules and offends the language of chemistry: “1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid could be parsed but OPSIN was unsure of the meaning of the words. This error will occur, by default, if a name is just a substituent”
US: CSA Schedule I Section h Subsection 7 Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate
Effective 16 Jul 2015, SOR/2015-192 added:
(ii)
1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5F-PB-22)
The Open Parser for Systematic IUPAC nomenclature (OPSIN), a superlative work of software design and engineering in my view, quite properly says “1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid” circumvents the rules and offends the language of chemistry: “1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid could be parsed but OPSIN was unsure of the meaning of the words. This error will occur, by default, if a name is just a substituent”
US: CSA Schedule I Section h Subsection 8 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
Effective 16 Jul 2015, SOR/2015-192 added:
(8)
Any substance that has a 3-Carboxamideindazole structure with substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
The Open Parser for Systematic IUPAC nomenclature (OPSIN), a superlative work of software design and engineering in my view, quite properly says “3-Carboxamideindazole” circumvents the rules and offends the language of chemistry: “3-Carboxamideindazole was uninterpretable due to the following section of the name: 3-Carboxamide The following was not understandable in the context it was used: oxamide”
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide (AKB48)
US: CSA Schedule I Section h Subsection 3 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
US: [proposed] CSA Schedule I Section g Subsection 18 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
⇒
PubChem: 57404063; ChemSpider: 28189076; Bluelight: AKB48; Drugs Forum: AKB48; Wikipedia: AKB48 (drug)
Effective 16 Jul 2015, SOR/2015-192 added:
(ii)
Effective 16 Jul 2015, SOR/2015-192 added:
(iii)
N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)
US: CSA Schedule I Section h Subsection 9 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
Effective 16 Jul 2015, SOR/2015-192 added:
(iv)
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)
US: CSA Schedule I Section h Subsection 22 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
Effective 16 Jul 2015, SOR/2015-192 added:
(9)
Any substance that has a 3-Carboxamideindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
The Open Parser for Systematic IUPAC nomenclature (OPSIN), a superlative work of software design and engineering in my view, quite properly says “3-carboxamideindole” circumvents the rules and offends the language of chemistry: “3-carboxamideindole was uninterpretable due to the following section of the name: 3-carboxamide The following was not understandable in the context it was used: oxamide”
Effective 16 Jul 2015, SOR/2015-192 added:
(i)
N-(Adamantan-1-yl)-1-fluoropentylindole-3-carboxamide (STS-135)
⇒
PubChem: 57404059; ChemSpider: 28189067; Bluelight: STS-135; Drugs Forum: STS-135; Wikipedia: STS-135 (drug)
Effective 16 Jul 2015, SOR/2015-192 added:
(ii)
Schedule III
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
1.
Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
CA: Currently at CDSA Schedule I Section 19 Amphetamines
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(1)
Amphetamine (α-Methylbenzeneethanamine)
UK: MDA Part II Class B Section 1(a) Amphetamine
UN: Psychotropics Schedule II Amfetamine (Amphetamine)
US: CSA Schedule II Section d Subsection 1 Amphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 1 Amphetamine
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: AmphetamineEffective 10 Aug 2005, SOR/2005-235 revoked:
(2)
Methamphetamine (N,ɑ-Dimethylbenzeneethanamine)
CA: Currently at CDSA Schedule I Section 18 Methamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(3)
N-Ethylamphetamine (N-Ethyl-α-methylbenzeneethanamine)
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(4)
4-Methyl-2,5-dimethoxyamphetamine (2,5-Dimethoxy-4,α-dimethylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(5)
3,4-Methylenedioxyamphetamine (MDA) (α-Methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(6)
2,5-Dimethoxyamphetamine (2,5-Dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(7)
4-Methoxyamphetamine (4-Methoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(8)
2,4,5-Trimethoxyamphetamine (2,4,5-Trimethoxy-α-methylbenzeneethanamine)
EU: Substances Substances TMA-2
UK: MDA Part I Class A Section 1(c) 2,4,5-Trimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 7 2,4,5-Trimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(9)
N-Methyl-3,4-methylenedioxyamphetamine (N,α-Dimethyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(10)
4-Ethoxy-2,5-dimethoxyamphetamine (4-Ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethoxy-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 9 4-Ethoxy-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(11)
5-Methoxy-3,4-methylenedioxyamphetamine (7-Methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
US: CSA Schedule I Section d Subsection 8 5-Methoxy-3,4-methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(12)
N,N-Dimethyl-3,4-methylenedioxyamphetamine (N,N,α-Trimethyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(ba) Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
CA: Currently at CDSA Schedule I Section 19 Subsection 11 N,N-Dimethyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(13)
N-Ethyl-3,4-methylenedioxyamphetamine (N-Ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(14)
4-Ethyl-2,5-dimethoxyamphetamine (4-Ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(15)
4-Bromo-2,5-dimethoxyamphetamine (4-Bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(16)
4-Chloro-2,5-dimethoxyamphetamine (4-Chloro-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 15 4-Chloro-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(17)
4-Ethoxyamphetamine (4-Ethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 16 4-Ethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(18)
Benzphetamine (N-Benzyl-N,α-dimethylbenzeneethanamine)
UK: MDA Part III Class C Section 1(a) Benzphetamine
UN: Psychotropics Schedule IV Benzfetamine (Benzphetamine)
US: CSA Schedule III Section b Subsection 2 Benzphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 17 Benzphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(19)
N-Propyl-3,4-methylenedioxyamphetamine (α-Methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Propyl-3,4-methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 18 N-Propyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 22 Apr 1997, SOR/97-230 added:
(20)
N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
CA: Currently at CDSA Schedule I Section 19 Subsection 19 N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 30 Jan 2003, SOR/2003-32 added:
(21)
N-Hydroxy-3,4-methylenedioxyamphetamine (N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 30 Jan 2003, SOR/2003-32 added:
(22)
3,4,5-Trimethoxyamphetamine (3,4,5-Trimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
US: CSA Schedule I Section d Subsection 14 3,4,5-Trimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 10 Aug 2005, SOR/2005-235 added:
(23)
Methamphetamine (N,α-Dimethylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
CA: Currently at CDSA Schedule I Section 18 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
2.
Methylphenidate (α-Phenyl-2-piperidineacetic acid methyl ester) and any salt thereof
Effective 22 Apr 1997, SOR/97-230 replacement for:
Methylphenidate (α-Phenyl-2-pyridineacetic acid methyl ester) and any salt thereof
UK: MDA Part II Class B Section 1(a) Methylphenidate
UN: Psychotropics Schedule II Methylphenidate
US: CSA Schedule II Section d Subsection 4 Methylphenidate
⇒
PubChem: 4158; ChemSpider: 4015; Bluelight: Methylphenidate; Drugs Forum: Methylphenidate; Erowid: Methylphenidate; Wikipedia: Methylphenidate
3.
Methaqualone (2-Methyl-3-(2-methylphenyl)-4(3H)-quinazolinone) and any salt thereof
UK: MDA Part II Class B Section 1(a) Methaqualone
UN: Psychotropics Schedule II Methaqualone
US: CSA Schedule I Section e Subsection 3 Methaqualone
⇒
PubChem: 6292; ChemSpider: 6055; Bluelight: Methaqualone; Drugs Forum: Methaqualone; Erowid: Methaqualone; Wikipedia: Methaqualone
4.
Mecloqualone (2-Methyl-3-(2-chlorophenyl)-4(3H)-quinazolinone) and any salt thereof
UK: MDA Part II Class B Section 1(a) Mecloqualone
UN: Psychotropics Schedule II Mecloqualone
US: CSA Schedule I Section e Subsection 2 Mecloqualone
5.
Lysergic acid diethylamide (N,N-Diethyllysergamide) and any salt thereof
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
6.
N,N-Diethyltryptamine (3-[(2-Diethylamino)ethyl]indole) and any salt thereof
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
US: CSA Schedule I Section d Subsection 18 Diethyltryptamine
7.
N,N-Dimethyltryptamine (3-[(2-Dimethylamino)ethyl]indole) and any salt thereof
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
US: CSA Schedule I Section d Subsection 19 Dimethyltryptamine
8.
N-Methyl-3-piperidyl benzilate (LBJ) (3-[(Hydroxydiphenylacetyl)oxy]-1-methylpiperidine) and any salt thereof
US: CSA Schedule I Section d Subsection 28 N-Methyl-3-piperidyl benzilate
9.
Harmaline (4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole) and any salt thereof
⇒
PubChem: 5280951; ChemSpider: 10211258; Erowid: Harmala Alkaloids; TiHKAL • info: Harmaline; Wikipedia: Harmaline
11.
Psilocin (3-[2-(Dimethylamino)ethyl]-4-hydroxyindole) and any salt thereof
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
12.
Psilocybin (3-[2-(Dimethylamino)ethyl]-4-phosphoryloxyindole) and any salt thereof
UK: MDA Part I Class A Section 1(b) Psilocybin
UN: Psychotropics Schedule I Psilocybine
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
13.
N-(1-Phenylcyclohexyl)ethylamine and any salt thereof
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
![3D rendering of 1-[1-(2-Thienyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(2-Thienyl)cyclohexyl]piperidine")
14.
1-[1-(2-Thienyl)cyclohexyl]piperidine and any salt thereof
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
15.
1-Phenyl-N-propylcyclohexanamine and any salt thereof
UK: MDA Part II Class B Section 1(d) 1-Phenyl-N-propylcyclohexanamine
16.
Rolicyclidine (1-(1-Phenylcyclohexyl)pyrrolidine) and any salt thereof
Effective 30 Jan 2003, SOR/2003-32 replacement for:
1-(1-Phenylcyclohexyl)pyrrolidine and any salt thereof
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
17.
Mescaline (3,4,5-Trimethoxybenzeneethanamine) and any salt thereof, but not Lophophora
18.
4-Methylaminorex (4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine) and any salt thereof
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
UN: Psychotropics Schedule I 4-Methylaminorex
US: CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
20.
Fenetylline (dl-3,7-Dihydro-1,3-dimethyl-7-(2-[(1-methyl-2-phenethyl)amino]ethyl)-1H-purine-2,6-dione) and any salt thereof
UK: MDA Part III Class C Section 1(a) Fenethylline
UN: Psychotropics Schedule II Fenetylline
US: CSA Schedule I Section f Subsection 4 Fenethylline
21.
2-Methylamino-1-phenyl-1-propanone and any salt thereof
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone![3D rendering of 1-[1-(Phenylmethyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(Phenylmethyl)cyclohexyl]piperidine")
![3D rendering of 1-[1-(4-Methylphenyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(4-Methylphenyl)cyclohexyl]piperidine")
23.
1-[1-(4-Methylphenyl)cyclohexyl]piperidine and any salt thereof
UK: MDA Part II Class B Section 1(d) 1-[1-(4-Methylphenyl)cyclohexyl]piperidine
Effective 22 Apr 1997, SOR/97-230 added:
24.
4-Bromo-2,5-dimethoxybenzeneethanamine and any salt, isomer or salt of isomer thereof
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
25.
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
Effective 1 Jun 2000, SOR/2000-220 replacement for:
On 27 Mar 1999, C. Gaz. 1999.I.926 proposed replacement for:
Effective 19 Mar 1998, SOR/98-173 added:
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Flunitrazepam
UN: Psychotropics Schedule III Flunitrazepam
US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
CA: Currently at CDSA Schedule I Section 20 Flunitrazepam
⇒
PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 19 Mar 1998, SOR/98-173 added:
26.
4-Hydroxybutanoic acid and any salt thereof
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
CA: Currently at CDSA Schedule I Section 21 4-Hydroxybutanoic acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Effective 30 Jan 2003, SOR/2003-32 added:
27.
Effective 30 Jan 2003, SOR/2003-32 added:
28.
Etryptamine (3-(2-Aminobutyl)indole) and any salt thereof
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
Effective 30 Jan 2003, SOR/2003-32 added:
29.
Lefetamine ((–)-N,N-Dimethyl-α-phenylbenzeneethanamine) and any salt thereof
UK: MDA Part II Class B Section 1(a) Lefetamine
UN: Psychotropics Schedule IV Lefetamine (SPA)
US: CSA Schedule IV Section f Subsection 12 SPA
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine
Effective 11 Dec 2003, SOR/2003-412 added:
32.
Amineptine (7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
UK: MDA Part III Class C Section 1(a) Amineptine
UN: Psychotropics Schedule II Amineptine
Effective 30 Mar 2012, SOR/2012-66 added:
33.
Benzylpiperazine (BZP; 1-Benzylpiperazine) and its salts, isomers and salts of isomers
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
US: CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
Effective 30 Mar 2012, SOR/2012-66 added:
34.
Trifluoromethylphenylpiperazine (TFMPP; 1-(3-Trifluoromethylphenyl)piperazine) and its salts, isomers and salts of isomers
⇒
PubChem: 4296; ChemSpider: 4145; Bluelight: BZP + TFMPP; Drugs Forum: TFMPP; Erowid: TFMPP; Wikipedia: TrifluoromethylphenylpiperazineSchedule IV
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
1.
Barbiturates, their salts and derivatives including
UK: MDA Part II Class B Section 1(b) Barbituric acid [5,5-disubstituted]
(1)
Allobarbital (5,5-Diallylbarbituric acid)
UN: Psychotropics Schedule IV Allobarbital
(3)
Amobarbital (5-Ethyl-5-(3-methylbutyl)barbituric acid)
UN: Psychotropics Schedule III Amobarbital
US: CSA Schedule II Section e Subsection 1 Amobarbital, Schedule III Section c Subsection 1 Item i Amobarbital and Subsection 2 Item i Amobarbital
(6)
Barbituric acid (2,4,6(1H,3H,5H)-Pyrimidinetrione)
US: CSA Schedule III Section c Subsection 3 Barbituric acid
(7)
Butabarbital (5-sec-Butyl-5-ethylbarbituric acid)
UN: Psychotropics Schedule IV Secbutabarbital
(8)
Butalbital (5-Allyl-5-isobutylbarbituric acid)
UN: Psychotropics Schedule III Butalbital
(10)
Butethal (5-Butyl-5-ethylbarbituric acid)
UN: Psychotropics Schedule IV Butobarbital
(11)
Cyclobarbital (5-(1-Cyclohexen-1-yl)-5-ethylbarbituric acid)
UN: Psychotropics Schedule III Cyclobarbital
(16)
Mephobarbital (5-Ethyl-1-methyl-5-phenylbarbituric acid)
US: CSA Schedule IV Section c Subsection 36 Methylphenobarbital
CA: Also at CDSA Schedule IV Section 1 Subsection 18 Methylphenobarbital
⇒
PubChem: 8271; ChemSpider: 7972; Bluelight: Methylphenobarbital; Erowid: Barbiturates; Wikipedia: Methylphenobarbital
(18)
Methylphenobarbital (5-Ethyl-1-methyl-5-phenylbarbituric acid)
UK: MDA Part II Class B Section 1(a) Methylphenobarbitone
UN: Psychotropics Schedule IV Methylphenobarbital
CA: Also at CDSA Schedule IV Section 1 Subsection 16 Mephobarbital
(20)
Pentobarbital (5-Ethyl-5-(1-methylbutyl)barbituric acid)
UN: Psychotropics Schedule III Pentobarbital
US: CSA Schedule II Section e Subsection 3 Pentobarbital, Schedule III Section c Subsection 1 Item iii Pentobarbital and Subsection 2 Item iii Pentobarbital
⇒
PubChem: 4737; ChemSpider: 4575; Bluelight: Pentobarbital; Drugs Forum: Pentobarbital; Erowid: Barbiturates; Wikipedia: Pentobarbital
(21)
Phenobarbital (5-Ethyl-5-phenylbarbituric acid)
UN: Psychotropics Schedule IV Phenobarbital
US: CSA Schedule IV Section c Subsection 45 Phenobarbital
⇒
PubChem: 4763; ChemSpider: 4599; Bluelight: Phenobarbital vs. benzo's; Drugs Forum: Phenobarbital; Erowid: Barbiturates; Wikipedia: Phenobarbital
(24)
Secobarbital (5-Allyl-5-(1-methylbutyl)barbituric acid)
UN: Psychotropics Schedule II Secobarbital
US: CSA Schedule II Section e Subsection 5 Secobarbital, Schedule III Section c Subsection 1 Item ii Secobarbital and Subsection 2 Item ii Secobarbital
⇒
PubChem: 5193; ChemSpider: 5005; Bluelight: Secobarbital bioavailability; Drugs Forum: Secobarbital; Erowid: Barbiturates; Wikipedia: Secobarbital
(28)
Vinylbital (5-(1-Methylbutyl)-5-vinylbarbituric acid)
UN: Psychotropics Schedule IV Vinylbital
3.
Chlorphentermine (1-(p-Chlorophenyl)-2-methyl-2-aminopropane) and any salt thereof
UK: MDA Part III Class C Section 1(a) Chlorphentermine
US: CSA Schedule III Section b Subsection 3 Chlorphentermine
4.
Diethylpropion (2-(Diethylamino)propiophenone) and any salt thereof
UK: MDA Part II Class B Section 1(aa) Diethylpropion and Part III Class C Section 1(a) Diethylpropion
UN: Psychotropics Schedule IV Amfepramone (Diethylpropion)
US: CSA Schedule IV Section f Subsection 2 Diethylpropion
5.
Phendimetrazine (d-3,4-Dimethyl-2-phenylmorpholine) and any salt thereof
UK: MDA Part III Class C Section 1(a) Phendimetrazine
UN: Psychotropics Schedule IV Phendimetrazine
US: CSA Schedule III Section b Subsection 5 Phendimetrazine
6.
Phenmetrazine (3-Methyl-2-phenylmorpholine) and any salt thereof
UK: MDA Part II Class B Section 1(a) Phenmetrazine
UN: Psychotropics Schedule II Phenmetrazine
US: CSA Schedule II Section d Subsection 3 Phenmetrazine
8.
Phentermine (α,α-Dimethylbenzeneethanamine) and any salt thereof
UK: MDA Part III Class C Section 1(a) Phentermine
UN: Psychotropics Schedule IV Phentermine
US: CSA Schedule IV Section f Subsection 9 Phentermine
9.
Butorphanol (l-N-Cyclobutylmethyl-3,14-dihydroxymorphinan) and any salt thereof
US: CSA Schedule IV Section g Subsection 2 Butorphanol
10.
Nalbuphine (N-Cyclobutylmethyl-4,5-epoxymorphinan-3,6,14-triol) and any salt thereof
⇒
PubChem: 16757775 11957646 12898403 6604372 6603947 5360630 5311304; ChemSpider: 4514550; Wikipedia: Nalbuphine
11.
Glutethimide (2-Ethyl-2-phenylglutarimide)
UK: MDA Part II Class B Section 1(a) Glutethimide
UN: Psychotropics Schedule III Glutethimide
US: CSA Schedule II Section e Subsection 2 Glutethimide
12.
Clotiazepam (5-(o-Chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one) and any salt thereof
Effective 21 Oct 1999, SOR/99-421 replacement for:
Clotiazepam ((5-(o-Chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one) and any salt thereof
Effective 22 Apr 1997, SOR/97-230 replacement for:
Clotiazepam (5-(o-Chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one)
UK: MDA Part III Class C Section 1(a) Clotiazepam
UN: Psychotropics Schedule IV Clotiazepam
US: CSA Schedule IV Section c Subsection 13 Clotiazepam
13.
Ethchlorvynol (Ethyl-2-chlorovinyl ethynyl carbinol)
UK: MDA Part III Class C Section 1(a) Ethchlorvynol
UN: Psychotropics Schedule IV Ethchlorvynol
US: CSA Schedule IV Section c Subsection 19 Ethchlorvynol
14.
Ethinamate (1-Ethynylcyclohexanol carbamate)
UK: MDA Part III Class C Section 1(a) Ethinamate
UN: Psychotropics Schedule IV Ethinamate
US: CSA Schedule IV Section c Subsection 20 Ethinamate
16.
Meprobamate (2-Methyl-2-propyl-1,3-propanediol dicarbamate)
UK: MDA Part III Class C Section 1(a) Meprobamate
UN: Psychotropics Schedule IV Meprobamate
US: CSA Schedule IV Section c Subsection 34 Meprobamate
17.
Methyprylon (3,3-Diethyl-5-methyl-2,4-piperidinedione)
UK: MDA Part III Class C Section 1(a) Methyprylone
UN: Psychotropics Schedule IV Methyprylon
US: CSA Schedule III Section c Subsection 10 Methyprylon
(1)
Alprazolam (8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine)
UK: MDA Part III Class C Section 1(a) Alprazolam
UN: Psychotropics Schedule IV Alprazolam
US: CSA Schedule IV Section c Subsection 2 Alprazolam
⇒
PubChem: 2118; ChemSpider: 2034; Bluelight: Alprazolam; Drugs Forum: Alprazolam; Erowid: Alprazolam; Wikipedia: Alprazolam
(2)
Bromazepam (7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Bromazepam
UN: Psychotropics Schedule IV Bromazepam
US: CSA Schedule IV Section c Subsection 4 Bromazepam
⇒
PubChem: 2441; ChemSpider: 2347; Drugs Forum: Bromazepam; Erowid: Bromazepam; Wikipedia: Bromazepam
Effective 1 Jun 2000, SOR/2000-220 added:
On 27 Mar 1999, C. Gaz. 1999.I.926 proposed to add:
(2.1)
Brotizolam (2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)
UK: MDA Part III Class C Section 1(a) Brotizolam
UN: Psychotropics Schedule IV Brotizolam
(4)
Chlordiazepoxide (7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide)
UK: MDA Part III Class C Section 1(a) Chlordiazepoxide
UN: Psychotropics Schedule IV Chlordiazepoxide
US: CSA Schedule IV Section c Subsection 9 Chlordiazepoxide
⇒
PubChem: 2712; ChemSpider: 10248513; Drugs Forum: Chlordiazepoxide; Erowid: Chlordiazepoxide; Wikipedia: Chlordiazepoxide
(6)
Clonazepam (5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Clonazepam
UN: Psychotropics Schedule IV Clonazepam
US: CSA Schedule IV Section c Subsection 11 Clonazepam
⇒
PubChem: 2802; ChemSpider: 2700; Bluelight: Clonazepam; Drugs Forum: Clonazepam; Erowid: Clonazepam; Wikipedia: Clonazepam
(7)
Clorazepate (7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid)
The upper diagram corresponds to the chemical name given in the Act. The lower diagram corresponds to the structure according to other sources, including the Merck Index.
UK: MDA Part III Class C Section 1(a) Clorazepic acid
UN: Psychotropics Schedule IV Clorazepate
US: CSA Schedule IV Section c Subsection 12 Clorazepate
(8)
Cloxazolam (10-Chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one)
UK: MDA Part III Class C Section 1(a) Cloxazolam
UN: Psychotropics Schedule IV Cloxazolam
US: CSA Schedule IV Section c Subsection 14 Cloxazolam
(9)
Delorazepam (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Delorazepam
UN: Psychotropics Schedule IV Delorazepam
US: CSA Schedule IV Section c Subsection 15 Delorazepam
(12)
Ethyl loflazepate (Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate)
UK: MDA Part III Class C Section 1(a) Ethyl loflazepate
UN: Psychotropics Schedule IV Ethyl loflazepate
US: CSA Schedule IV Section c Subsection 21 Ethyl loflazepate
(13)
Fludiazepam (7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Fludiazepam
UN: Psychotropics Schedule IV Fludiazepam
US: CSA Schedule IV Section c Subsection 22 Fludiazepam
Effective 19 Mar 1998, SOR/98-173 revoked:
(14)
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one)
CA: Currently at CDSA Schedule I Section 20 Flunitrazepam
(15)
Flurazepam (7-Chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Flurazepam
UN: Psychotropics Schedule IV Flurazepam
US: CSA Schedule IV Section c Subsection 24 Flurazepam
(17)
Haloxazolam (10-Bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one)
UK: MDA Part III Class C Section 1(a) Haloxazolam
UN: Psychotropics Schedule IV Haloxazolam
US: CSA Schedule IV Section c Subsection 27 Haloxazolam
(19)
Loprazolam (6-(o-Chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepine-1-one)
UK: MDA Part III Class C Section 1(a) Loprazolam
UN: Psychotropics Schedule IV Loprazolam
US: CSA Schedule IV Section c Subsection 29 Loprazolam
(21)
Lormetazepam (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Lormetazepam
UN: Psychotropics Schedule IV Lormetazepam
US: CSA Schedule IV Section c Subsection 31 Lormetazepam
Effective 1 Jun 2000, SOR/2000-220 added:
On 27 Mar 1999, C. Gaz. 1999.I.926 proposed to add:
(22.1)
Midazolam (8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine)
(23)
Nimetazepam (1,3-Dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Nimetazepam
UN: Psychotropics Schedule IV Nimetazepam
US: CSA Schedule IV Section c Subsection 38 Nimetazepam
⇒
PubChem: 4496; ChemSpider: 4340; Drugs Forum: Nimetazepam; Erowid: Nimetazepam; Wikipedia: Nimetazepam
(24)
Nitrazepam (1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Nitrazepam
UN: Psychotropics Schedule IV Nitrazepam
US: CSA Schedule IV Section c Subsection 39 Nitrazepam
⇒
PubChem: 4506; ChemSpider: 4350; Drugs Forum: Nitrazepam; Erowid: Nitrazepam Synthesis; Wikipedia: Nitrazepam
(25)
Nordazepam (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Nordazepam (7-Chloro-1,3-dihydro-5-phenyl-1-(2H)-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Nordazepam
UN: Psychotropics Schedule IV Nordazepam
US: CSA Schedule IV Section c Subsection 40 Nordiazepam
⇒
PubChem: 2997; ChemSpider: 2890; Bluelight: Nordiazepam ; Erowid: Nordiazepam Synthesis; Wikipedia: Nordazepam
Effective 1 Jun 2000, SOR/2000-220 added:
On 27 Mar 1999, C. Gaz. 1999.I.926 proposed to add:
(29.1)
(31)
Tetrazepam (7-Chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Tetrazepam (7-Chloro-5-(cyclohexen-1-yl)-1-2,3-dihydro-1-methyl-2H-1,4-benzodiazepin-one)
UK: MDA Part III Class C Section 1(a) Tetrazepam
UN: Psychotropics Schedule IV Tetrazepam
US: CSA Schedule IV Section c Subsection 51 Tetrazepam
⇒
PubChem: 25215; ChemSpider: 23551; Bluelight: Tetrazepam; Drugs Forum: Tetrazepam; Wikipedia: Tetrazepam
but not including
Effective 1 Jun 2000, SOR/2000-220 added:
On 27 Mar 1999, C. Gaz. 1999.I.926 proposed to add:
(32.1)
(33)
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
Effective 1 Jun 2000, SOR/2000-220 replacement for:
On 27 Mar 1999, C. Gaz. 1999.I.926 proposed replacement for:
Effective 19 Mar 1998, SOR/98-173 added:
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Flunitrazepam
UN: Psychotropics Schedule III Flunitrazepam
US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
See also CDSA Schedule I Section 20 Flunitrazepam
⇒
PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
Effective 29 Sep 1999, SOR/99-371 added:
(34)
Olanzapine (2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) and its salts
20.
Fencamfamin (dl-N-Ethyl-3-phenylbicyclo[2,2,1]heptan-2-amine) and any salt thereof
The chemical name in the Act is incorrect. A correct name is dl-N-Ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine
UK: MDA Part III Class C Section 1(a) Fencamfamin
UN: Psychotropics Schedule IV Fencamfamin
US: CSA Schedule IV Section f Subsection 3 Fencamfamin
21.
Fenproporex (dl-3-[(α-Methylphenethyl)amino]propionitrile) and any salt thereof
UK: MDA Part III Class C Section 1(a) Fenproporex
UN: Psychotropics Schedule IV Fenproporex
US: CSA Schedule IV Section f Subsection 4 Fenproporex
23.
Anabolic steroids and their derivatives including:
Readers wanting to explore the intricacies of steroid nomenclature may find this steroid crib sheet useful.
(2)
Androstanolone (17β-Hydroxy-5α-androstan-3-one)
UK: MDA Part III Class C Section 1(b) Stanolone
US: CSA Schedule III Section f Subsection 1 Item 19 4-Dihydrotestosterone
(3)
Androstenediol (Androst-5-ene-3β,17β-diol)
UK: MDA Part III Class C Section 1(b) 5-Androstene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 7 5-Androstenediol
(5)
Bolasterone (17β-Hydroxy-7α,17-dimethylandrost-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Bolasterone
US: CSA Schedule III Section f Subsection 1 Item 11 Bolasterone
(6)
Bolazine (17β-Hydroxy-2α-methyl-5α-androstan-3-one azine)
UK: MDA Part III Class C Section 1(b) Bolazine
(8)
Bolenol (19-Nor-17α-pregn-5-en-17-ol)
UK: MDA Part III Class C Section 1(b) Bolenol
(9)
Calusterone (17β-Hydroxy-7β,17-dimethylandrost-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Calusterone
US: CSA Schedule III Section f Subsection 1 Item 14 Calusterone
(11)
Drostanolone (17β-Hydroxy-2α-methyl-5α-androstan-3-one)
UK: MDA Part III Class C Section 1(b) Drostanolone
US: CSA Schedule III Section f Subsection 1 Item 20 Drostanolone
(13)
Epitiostanol (2α,3α-Epithio-5α-androstan-17β-ol)
UK: MDA Part III Class C Section 1(b) Epitiostanol
(14)
Ethylestrenol (19-Nor-17α-pregn-4-en-17-ol)
UK: MDA Part III Class C Section 1(b) Ethyloestrenol
US: CSA Schedule III Section f Subsection 1 Item 21 Ethylestrenol
(16)
Fluoxymesterone (9-Fluoro-11β,17β-dihydroxy-17-methylandrost-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Fluoxymesterone
US: CSA Schedule III Section f Subsection 1 Item 22 Fluoxymesterone
(17)
Formebolone (11α,17β-Dihydroxy-17-methyl-3-oxoandrosta-1,4-dien-2-carboxaldehyde)
UK: MDA Part III Class C Section 1(b) Formebolone
US: CSA Schedule III Section f Subsection 1 Item 23 Formebolone
(19)
Mebolazine (17β-Hydroxy-2α,17-dimethyl-5α-androstan-3-one azine)
UK: MDA Part III Class C Section 1(b) Mebolazine
(20)
Mesabolone (17β-[(1-Methoxycyclohexyl)oxy]-5α-androst-1-en-3-one)
UK: MDA Part III Class C Section 1(b) Mesabolone
(21)
Mesterolone (17β-Hydroxy-1α-methyl-5α-androstan-3-one)
UK: MDA Part III Class C Section 1(b) Mesterolone
US: CSA Schedule III Section f Subsection 1 Item 29 Mesterolone
(22)
Metandienone (17β-Hydroxy-17-methylandrosta-1,4-dien-3-one)
UK: MDA Part III Class C Section 1(b) Methandienone
US: CSA Schedule III Section f Subsection 1 Item 30 Methandienone
(23)
Metenolone (17β-Hydroxy-1-methyl-5α-androst-1-en-3-one)
UK: MDA Part III Class C Section 1(b) Methenolone
US: CSA Schedule III Section f Subsection 1 Item 33 Methenolone
(24)
Methandriol (17α-Methylandrost-5-ene-3β,17β-diol)
UK: MDA Part III Class C Section 1(b) Methandriol
US: CSA Schedule III Section f Subsection 1 Item 31 Methandriol
(25)
Methyltestosterone (17β-Hydroxy-17-methylandrost-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Methyltestosterone
US: CSA Schedule III Section f Subsection 1 Item 40 Methyltestosterone
(26)
Metribolone (17β-Hydroxy-17-methylestra-4,9,11-trien-3-one)
UK: MDA Part III Class C Section 1(b) Metribolone
US: CSA Schedule III Section f Subsection 1 Item 39 Methyltrienolone
(27)
Mibolerone (17β-Hydroxy-7α,17-dimethylestr-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Mibolerone
US: CSA Schedule III Section f Subsection 1 Item 41 Mibolerone
(28)
Nandrolone (17β-Hydroxyestra-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Nandrolone
US: CSA Schedule III Section f Subsection 1 Item 43 Nandrolone
(29)
Norboletone (13-Ethyl-17β-hydroxy-18,19-dinorpregn-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Norboletone
US: CSA Schedule III Section f Subsection 1 Item 51 Norbolethone
(30)
Norclostebol (4-Chloro-17β-hydroxyestr-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Norclostebol
US: CSA Schedule III Section f Subsection 1 Item 52 Norclostebol
(31)
Norethandrolone (17α-Ethyl-17β-hydroxyestr-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Norethandrolone
US: CSA Schedule III Section f Subsection 1 Item 53 Norethandrolone
(32)
Oxabolone (4,17β-Dihydroxyestr-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Oxabolone
CA: Also at CDSA Schedule IV Section 23 Subsection 15 4-Hydroxy-19-nortestosterone
(33)
Oxandrolone (17β-Hydroxy-17-methyl-2-oxa-5α-androstan-3-one)
UK: MDA Part III Class C Section 1(b) Oxandrolone
US: CSA Schedule III Section f Subsection 1 Item 55 Oxandrolone
⇒
PubChem: 5878; ChemSpider: 5667; Bluelight: Oxandrolone; Drugs Forum: Oxandrolone; Erowid: Steroids; Wikipedia: Oxandrolone
(34)
Oxymesterone (4,17β-Dihydroxy-17-methylandrosta-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Oxymesterone
US: CSA Schedule III Section f Subsection 1 Item 56 Oxymesterone
(35)
Oxymetholone (17β-Hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one)
UK: MDA Part III Class C Section 1(b) Oxymetholone
US: CSA Schedule III Section f Subsection 1 Item 57 Oxymetholone
⇒
PubChem: 3032303; ChemSpider: 4444502; Bluelight: Oxymetholone; Erowid: Steroids; Wikipedia: Oxymetholone
(36)
Prasterone (3β-Hydroxyandrost-5-en-17-one)
UK: MDA Part III Class C Section 1(b) Prasterone
(37)
Quinbolone (17β-(1-Cyclopenten-1-yloxy)androsta-1,4-dien-3-one)
UK: MDA Part III Class C Section 1(b) Quinbolone
(38)
Stanozolol (17β-Hydroxy-17-methyl-5α-androstano[3,2-c]pyrazole)
UK: MDA Part III Class C Section 1(b) Stanozolol
US: CSA Schedule III Section f Subsection 1 Item 59 Stanozolol
(39)
Stenbolone (17β-Hydroxy-2-methyl-5α-androst-1-en-3-one)
UK: MDA Part III Class C Section 1(b) Stenbolone
US: CSA Schedule III Section f Subsection 1 Item 60 Stenbolone
(40)
Testosterone (17β-Hydroxyandrost-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Testosterone
US: CSA Schedule III Section f Subsection 1 Item 62 Testosterone
(41)
Tibolone ((7α,17α)-17-Hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Tibolone (17-Hydroxy-7α-methyl-19-norpregn-5(10)-en-20-yn-3-one)
(42)
Tiomesterone (1α,7α-Bis(acetylthio)-17β-hydroxy-17-methylandrost-4-en-3-one)
UK: MDA Part III Class C Section 1(b) Thiomesterone
(43)
Trenbolone (17β-Hydroxyestra-4,9,11-trien-3-one)
UK: MDA Part III Class C Section 1(b) Trenbolone
US: CSA Schedule III Section f Subsection 1 Item 64 Trenbolone
Effective 30 Jan 2003, SOR/2003-37 added:
25.
Zolpidem (N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof
Effective 30 Jan 2003, SOR/2003-32 added:
25.1
Pemoline (2-Amino-5-phenyloxazolin-4-one) and any salt thereof
Effective 30 Jan 2003, SOR/2003-32 added:
26.
Pyrovalerone (4ʹ-Methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof
UK: MDA Part II Class B Section 1(aa) Pyrovalerone and Part III Class C Section 1(a) Pyrovalerone
UN: Psychotropics Schedule IV Pyrovalerone
US: CSA Schedule V Section d Subsection 1 Pyrovalerone
Effective 31 Jul 2015, SOR/2015-209 added:
27.
Salvia divinorum (S. divinorum), its preparations and derivatives, including:
Effective 31 Jul 2015, SOR/2015-209 added:
(1)
Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(Acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)
⇒
PubChem: 128563; ChemSpider: 113947; Bluelight: Salvinorin A; Drugs Forum: Salvinorin A; Erowid: Salvia Divinorum; Wikipedia: Salvinorin ASchedule V
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
Effective 24 Sep 2002, SOR/2002-361 revoked:
1.
Phenylpropanolamine (2-Amino-1-phenyl-1-propanol) and any salt thereof
CA: Currently at CDSA Schedule VI Part 1 Subsection 10 Norephedrine
Effective 30 Jan 2003, SOR/2003-32 revoked:
3.
Pyrovalerone (1-(1-Pyrrolidinyl)butyl p-tolyl ketone) and any salt thereof
CA: Currently at CDSA Schedule IV Section 26 Pyrovalerone
Schedule VI
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
Effective 24 Sep 2002, SOR/2002-361 revoked:
1.
Benzyl methyl ketone (P2P)
CA: Currently at CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
Effective 24 Sep 2002, SOR/2002-361 revoked:
2.
Ephedrine (l-erythro-2-(Methylamino)-1-phenylpropan-1-ol)
CA: Currently at CDSA Schedule VI Part 1 Subsection 4 Ephedrine
Effective 24 Sep 2002, SOR/2002-361 revoked:
3.
Ergometrine (9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide)
CA: Currently at CDSA Schedule VI Part 1 Subsection 5 Ergometrine
Effective 24 Sep 2002, SOR/2002-361 revoked:
4.
Ergotamine (12′-Hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione)
CA: Currently at CDSA Schedule VI Part 1 Subsection 6 Ergotamine
Effective 24 Sep 2002, SOR/2002-361 revoked:
5.
Lysergic acid (9,10-Didehydro-6-methylergoline-8-carboxylic acid)
CA: Currently at CDSA Schedule VI Part 1 Subsection 8 Lysergic acid
Effective 24 Sep 2002, SOR/2002-361 revoked:
6.
Pseudoephedrine (d-threo-2-(Methylamino)-1-phenylpropan-1-ol)
CA: Currently at CDSA Schedule VI Part 1 Subsection 16 Pseudoephedrine
Effective 24 Sep 2002, SOR/2002-361 added:
Part 1 · Class A Precursors
Each Class A precursor includes synthetic and natural forms.
Effective 24 Sep 2002, SOR/2002-361 added:
1.
Acetic anhydride
EU: Drug precursors Annex I Category 2 Acetic anhydride and Annex II Acetic anhydride
UK: MDA Drug precursors Annex I Category 2 Acetic anhydride and Drug precursors Annex II Acetic anhydride
UN: Precursors Table I Acetic anhydride
US: CSA Listed Chemicals Section b Subsection 1 Acetic anhydride
Effective 24 Sep 2002, SOR/2002-361 added:
2.
N-Acetylanthranilic acid (2-Acetamidobenzoic acid) and its salts
[With thanks to the reader who advised me the name 2-Acetamidobenzoic acid is an acceptable synonym for N-Acetylanthranilic acid—I had previously stated the name was in error.]
EU: Drug precursors Annex I Category 1 N-Acetylanthranilic acid
UK: MDA Drug precursors Annex I Category 1 N-Acetylanthranilic acid
UN: Precursors Table I N-Acetylanthranilic acid
US: CSA Listed Chemicals Section a Subsection 6 N-Acetylanthranilic acid
Effective 24 Sep 2002, SOR/2002-361 added:
3.
Anthranilic acid (2-Aminobenzoic acid) and its salts
EU: Drug precursors Annex I Category 2 Anthranilic acid and Annex II Anthranilic acid
UK: MDA Drug precursors Annex I Category 2 Anthranilic acid and Drug precursors Annex II Anthranilic acid
UN: Precursors Table II Anthranilic acid
US: CSA Listed Chemicals Section a Subsection 1 Anthranilic acid
Effective 24 Sep 2002, SOR/2002-361 added:
4.
Ephedrine (erythro-2-(Methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts
Before it was moved from Schedule VI, Section 2 by SOR/2002-361, the extended chemical name for Ephedrine described a single stereoisomer, specifically, the levo (l) isomer, depicted at left.
The systematic name for Ephedrine currently in the CDSA is not specific to a particular stereoisomer. Hence, it is unclear if the current designation of Ephedrine is meant to encompass the dextro isomer, the levo isomer, the racemate (a 1:1 mixture of dextro and levo isomers), or all three.
Effective 24 Sep 2002, SOR/2002-361 added:
5.
Ergometrine (9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts
EU: Drug precursors Annex I Category 1 Ergometrine
UK: MDA Drug precursors Annex I Category 1 Ergometrine
UN: Precursors Table I Ergometrine
US: CSA Listed Chemicals Section a Subsection 4 Ergonovine
Effective 24 Sep 2002, SOR/2002-361 added:
6.
Ergotamine (12ʹ-Hydroxy-2ʹ-methyl-5ʹ-(phenylmethyl)ergotaman-3ʹ,6ʹ,18-trione) and its salts
EU: Drug precursors Annex I Category 1 Ergotamine
UK: MDA Drug precursors Annex I Category 1 Ergotamine
UN: Precursors Table I Ergotamine
US: CSA Listed Chemicals Section a Subsection 5 Ergotamine
Effective 24 Sep 2002, SOR/2002-361 added:
7.
Isosafrole (5-(1-Propenyl)-1,3-benzodioxole)
EU: Drug precursors Annex I Category 1 Isosafrole
UK: MDA Drug precursors Annex I Category 1 Isosafrole
UN: Precursors Table I Isosafrole
US: CSA Listed Chemicals Section a Subsection 16 Isosafrole
Effective 24 Sep 2002, SOR/2002-361 added:
8.
Lysergic acid (9,10-Didehydro-6-methylergoline-8-carboxylic acid) and its salts
EU: Drug precursors Annex I Category 1 Lysergic acid
UK: MDA Drug precursors Annex I Category 1 Lysergic acid
UN: Precursors Table I Lysergic acid
US: CSA Schedule III Section c Subsection 8 Lysergic acid
Effective 24 Sep 2002, SOR/2002-361 added:
9.
3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-Benzodioxole)-2-propanone)
EU: Drug precursors Annex I Category 1 3,4-Methylenedioxyphenylpropan-2-one
UK: MDA Drug precursors Annex I Category 1 3,4-Methylenedioxyphenyl-2-propanone
UN: Precursors Table I 3,4-Methylenedioxyphenyl-2-propanone
US: CSA Listed Chemicals Section a Subsection 12 3,4-Methylenedioxyphenyl-2-propanone
Effective 24 Sep 2002, SOR/2002-361 added:
10.
Norephedrine (Phenylpropanolamine)
EU: Drug precursors Annex I Category 1 Norephedrine
UK: MDA Drug precursors Annex I Category 1 Norephedrine
UN: Precursors Table I Norephedrine
US: CSA Listed Chemicals Section a Subsection 9 Phenylpropanolamine
⇒
PubChem: 10297 26934; ChemSpider: 9875; Bluelight: Phenylpropanolamine; Erowid: Phenylpropanolamine; Wikipedia: Phenylpropanolamine
Effective 24 Sep 2002, SOR/2002-361 added:
11.
1-Phenyl-2-propanone
EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UK: MDA Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UN: Precursors Table I 1-Phenyl-2-propanone
US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
Effective 24 Sep 2002, SOR/2002-361 added:
12.
Phenylacetic acid and its salts
EU: Drug precursors Annex I Category 2 Phenylacetic acid and Annex II Phenylacetic acid
UK: MDA Drug precursors Annex I Category 2 Phenylacetic acid and Drug precursors Annex II Phenylacetic acid
UN: Precursors Table II Phenylacetic acid
US: CSA Listed Chemicals Section a Subsection 8 Phenylacetic acid
⇒
PubChem: 999; ChemSpider: 10181341; Erowid: Phenylacetic acid synthesis; Wikipedia: Phenylacetic acid
Effective 24 Sep 2002, SOR/2002-361 added:
13.
Piperidine and its salts
EU: Drug precursors Annex I Category 2 Piperidine and Annex II Piperidine
UK: MDA Drug precursors Annex I Category 2 Piperidine and Drug precursors Annex II Piperidine
UN: Precursors Table II Piperidine
US: CSA Listed Chemicals Section a Subsection 10 Piperidine
⇒
PubChem: 8082; ChemSpider: 7791; Drugs Forum: Piperidines; Erowid: Piperidine; Wikipedia: Piperidine
Effective 24 Sep 2002, SOR/2002-361 added:
15.
Potassium permanganate
EU: Drug precursors Annex I Category 2 Potassium permanganate and Annex II Potassium permanganate
UK: MDA Drug precursors Annex I Category 2 Potassium permanganate and Drug precursors Annex II Potassium permanganate
UN: Precursors Table I Potassium permanganate
US: CSA Listed Chemicals Section b Subsection 5 Potassium permanganate
⇒
PubChem: 516875; ChemSpider: 22810; Bluelight: KMnO4 substitute; Wikipedia: Potassium permanganate
Effective 24 Sep 2002, SOR/2002-361 added:
16.
Pseudoephedrine (threo-2-(Methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts
Before it was moved from Schedule VI, Section 6 by SOR/2002-361, the extended chemical name for Pseudoephedrine described a single stereoisomer, specifically, the levo (l) isomer, depicted at left.
The systematic name for Pseudoephedrine currently in the CDSA is not specific to a particular stereoisomer. Hence, it is unclear if the current designation of Pseudoephedrine is meant to encompass the dextro isomer, the levo isomer, the racemate (a 1:1 mixture of dextro and levo isomers), or all three.
EU: Drug precursors Annex I Category 1 Pseudoephedrine
UK: MDA Drug precursors Annex I Category 1 Pseudoephedrine
UN: Precursors Table I Pseudoephedrine
US: CSA Listed Chemicals Section a Subsection 11 Pseudoephedrine
⇒
PubChem: 7028; ChemSpider: 6761; Bluelight: Pseudoephedrine; Drugs Forum: Pseudoephedrine; Erowid: Ephedrine; Wikipedia: Pseudoephedrine
17.
Safrole (5-(2-Propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% Safrole
Effective 21 Nov 2005, SOR/2005-364 replacement for:
Effective 24 Sep 2002, SOR/2002-361 added:
Safrole (5-(2-Propenyl)-1,3-benzodioxole) and any essential oil containing Safrole
Effective 21 Nov 2005, SOR/2005-364 added:
On 11 Jun 2005, C. Gaz. 2005.I.2098 proposed to add:
Effective 21 Jun 2003, C. Gaz. 2003.I.1918 added:
18.
Gamma-butyrolactone (Dihydro-2(3H)-furanone)
UK: MDA Part III Class C Section 1(a) Gamma-butyrolactone
US: CSA Listed Chemicals Section a Subsection 24 Gamma-butyrolactone
Effective 21 Nov 2005, SOR/2005-364 added:
On 11 Jun 2005, C. Gaz. 2005.I.2098 proposed to add:
Effective 21 Jun 2003, C. Gaz. 2003.I.1918 added:
19.
1,4-Butanediol
UK: MDA Part III Class C Section 1(b) 1,4-Butanediol
⇒
PubChem: 8064; ChemSpider: 13835209; Drugs Forum: 1,4-Butanediol; Erowid: 1,4-Butanediol; Wikipedia: 1,4-Butanediol[Red phosphorous is one form of elemental phosphorus.]
Effective 21 Nov 2005, SOR/2005-364 added:
On 11 Jun 2005, C. Gaz. 2005.I.2098 proposed to add:
Effective 8 Nov 2003, C. Gaz. 2003.I.3492 added:
20.
Red phosphorous
US: CSA Listed Chemicals Section a Subsection 25 Red phosphorus
[White phosphorous is one form of elemental phosphorus.]
Effective 21 Nov 2005, SOR/2005-364 added:
On 11 Jun 2005, C. Gaz. 2005.I.2098 proposed to add:
Effective 8 Nov 2003, C. Gaz. 2003.I.3492 added:
21.
White phosphorous
US: CSA Listed Chemicals Section a Subsection 26 White phosphorus
Effective 21 Nov 2005, SOR/2005-364 added:
On 11 Jun 2005, C. Gaz. 2005.I.2098 proposed to add:
22.
Hypophosphorous acid, its salts and derivatives
US: CSA Listed Chemicals Section a Subsection 27 Hypophosphorous acid
Effective 21 Nov 2005, SOR/2005-364 added:
On 11 Jun 2005, C. Gaz. 2005.I.2098 proposed to add:
23.
Hydriodic acid
US: CSA Listed Chemicals Section a Subsection 21 Hydriodic acid
Effective 24 Sep 2002, SOR/2002-361 added:
Part 2 · Class B Precursors
Each Class B precursor includes synthetic forms.
Effective 24 Sep 2002, SOR/2002-361 added:
2.
Ethyl ether
EU: Drug precursors Annex I Category 3 Ethyl ether
UK: MDA Drug precursors Annex I Category 3 Ethyl ether
UN: Precursors Table II Ethyl ether
US: CSA Listed Chemicals Section b Subsection 4 Ethyl ether
Effective 24 Sep 2002, SOR/2002-361 added:
3.
Hydrochloric acid
EU: Drug precursors Annex I Category 3 Hydrochloric acid
UK: MDA Drug precursors Annex I Category 3 Hydrochloric acid
UN: Precursors Table II Hydrochloric acid
US: CSA Listed Chemicals Section b Subsection 8 Hydrochloric acid
Effective 24 Sep 2002, SOR/2002-361 added:
4.
Methyl ethyl ketone
EU: Drug precursors Annex I Category 3 Methylethylketone
UK: MDA Drug precursors Annex I Category 3 Methyl ethyl ketone
UN: Precursors Table II Methyl ethyl ketone
US: CSA Listed Chemicals Section b Subsection 6 2-Butanone
Effective 24 Sep 2002, SOR/2002-361 added:
5.
Sulphuric acid
EU: Drug precursors Annex I Category 3 Sulphuric acid
UK: MDA Drug precursors Annex I Category 3 Sulphuric acid
UN: Precursors Table II Sulphuric acid
US: CSA Listed Chemicals Section b Subsection 9 Sulfuric acid
Effective 24 Sep 2002, SOR/2002-361 added:
6.
Effective 24 Sep 2002, SOR/2002-361 added:
Part 3 · Preparations and Mixtures
1.
Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23, or in Part 2
Effective 21 Nov 2005, SOR/2005-364 replacement for:
On 11 Jun 2005, C. Gaz. 2005.I.2098 proposed replacement for:
Effective 24 Sep 2002, SOR/2002-361 added:
Any preparation or mixture that contains a precursor set out in Part 1 or Part 2.
Schedule VII
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
1.
Cannabis resin<div>
3 kg<div>
UK: MDA Part II Class B Section 1(a) Cannabis resin
UN: Narcotics Part 1 Section 1 Cannabis resin and Section 3 Cannabis resin
See also CDSA Schedule II Section 1 Subsection 1 Cannabis resin and Schedule VIII Section 1 Cannabis resin
2.
Schedule VIII
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
1.
Cannabis resin<div>
1 g<div>
UK: MDA Part II Class B Section 1(a) Cannabis resin
UN: Narcotics Part 1 Section 1 Cannabis resin and Section 3 Cannabis resin
See also CDSA Schedule II Section 1 Subsection 1 Cannabis resin and Schedule VII Section 1 Cannabis resin
2.
Cannabis (Marihuana)<div>
30 g<div>
Effective 22 Apr 1997, SOR/97-230 replacement for:
Cannabis (Marihuana)
3o g
11 March 2016 · 
· Isomer Design
· Isomer Design